Author: "Rico A" / Topic: diagnosis - Searchworks@Jio Institute Digital Library Search Results

Your search keyword '"Rico A"' showing total 164 results

Start Over Author "Rico A" Topic diagnosis

164 results on '"Rico A"'

1. Challenges and recommendations to increasing the use of exome sequencing and whole genome sequencing for diagnosing rare diseases in Brazil: an expert perspective

Author: Félix, Têmis Maria, Fischinger Moura de Souza, Carolina, Oliveira, João Bosco, Rico-Restrepo, Mariana, Zanoteli, Edmar, Zatz, Mayana, and Giugliani, Roberto
Published: 2023
Full Text: View/download PDF

2. Bayesian Networks for the Diagnosis and Prognosis of Diseases: A Scoping Review.

Author: Polotskaya, Kristina, Muñoz-Valencia, Carlos S., Rabasa, Alejandro, Quesada-Rico, Jose A., Orozco-Beltrán, Domingo, and Barber, Xavier
Subjects: BAYESIAN analysis, PROGNOSIS, DIAGNOSIS, BAYES' theorem, SCIENCE databases
Abstract: Bayesian networks (BNs) are probabilistic graphical models that leverage Bayes' theorem to portray dependencies and cause-and-effect relationships between variables. These networks have gained prominence in the field of health sciences, particularly in diagnostic processes, by allowing the integration of medical knowledge into models and addressing uncertainty in a probabilistic manner. Objectives: This review aims to provide an exhaustive overview of the current state of Bayesian networks in disease diagnosis and prognosis. Additionally, it seeks to introduce readers to the fundamental methodology of BNs, emphasising their versatility and applicability across varied medical domains. Employing a meticulous search strategy with MeSH descriptors in diverse scientific databases, we identified 190 relevant references. These were subjected to a rigorous analysis, resulting in the retention of 60 papers for in-depth review. The robustness of our approach minimised the risk of selection bias. Results: The selected studies encompass a wide range of medical areas, providing insights into the statistical methodology, implementation feasibility, and predictive accuracy of BNs, as evidenced by an average area under the curve (AUC) exceeding 75%. The comprehensive analysis underscores the adaptability and efficacy of Bayesian networks in diverse clinical scenarios. The majority of the examined studies demonstrate the potential of BNs as reliable adjuncts to clinical decision-making. The findings of this review affirm the role of Bayesian networks as accessible and versatile artificial intelligence tools in healthcare. They offer a viable solution to address complex medical challenges, facilitating timely and informed decision-making under conditions of uncertainty. The extensive exploration of Bayesian networks presented in this review highlights their significance and growing impact in the realm of disease diagnosis and prognosis. It underscores the need for further research and development to optimise their capabilities and broaden their applicability in addressing diverse and intricate healthcare challenges. [ABSTRACT FROM AUTHOR]
Published: 2024
Full Text: View/download PDF

3. El diagnóstico como base de la intervención educativa.

Author: Amaro Yepez, Adilene, Juárez Lucas, Plácido, Rodríguez Rico, Rocío, Soni Guillermo, Eutiquio, and Enríquez García, Fabián
Subjects: EDUCATIONAL objectives, EDUCATIONAL planning, DIAGNOSIS, ACTORS
Abstract: Copyright of Revista Biológico Agropecuaria Tuxpan is the property of Revista Biologico Agropecuaria Tuxpan and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Published: 2024
Full Text: View/download PDF

4. Granulomatous rosacea: a clue to the diagnosis of STAT1 gain of function in a child with immunodeficiency.

Author: Bonino, Cecilia Buján, Arias, Noelia Moreiras, Rico, María López-Pardo, Franco, Montserrat López, Loidi, Lourdes, Peñaranda, José Manuel Suárez, and Osorio, Igor Vázquez
Subjects: STAT proteins, DIAGNOSIS, ROSACEA, IMMUNODEFICIENCY, GAIN-of-function mutations
Abstract: This article discusses a case study of a 4-year-old boy with recalcitrant granulomatous rosacea, a skin condition characterized by inflammatory papules and pustules on the face. The boy also experienced recurring oral aphthae, conjunctivitis, viral warts, and oral candidiasis. Genetic testing revealed a gain-of-function mutation in the STAT1 gene, which is associated with immunodeficiency. This case highlights the importance of considering STAT1 mutations in children with immunodeficiency and recalcitrant or extensive rosacea. [Extracted from the article]
Published: 2024
Full Text: View/download PDF

5. Advances in mechanical biomarkers.

Author: Eroles, Mar and Rico, Felix
Subjects: *BIOMARKERS, *PHYSICIANS, *BLOOD pressure measurement, *DRUG target, *INDIVIDUALIZED medicine
Abstract: Mechanical biomarkers distinguish health conditions through quantitative mechanical measurements. The emergence and establishment of nanotechnology in the last decades have provided new tools to obtain mechanical biomarkers at the nanoscale. Mechanical measurements are reproducible, label‐free, start to be applied in vivo can be high throughput, and require small samples. Mechanical protocols in clinical practice at the macro scale like palpation or blood pressure measurement are routinely used by medical doctors. Nanotechnology brought mechanical sensing to the next scale, where cells, tissues, and proteins can be probed and linked to medical conditions. Mechanical changes in cells and tissues may be detected before other markers, such as protein expression, providing an important advantage as biomarkers. In the present review, we explore the biomarker's historical evolution, describe mechanical biomarkers on various diseases and novel discoveries in the nanomechanical field for their characterization. We conclude that mechanical biomarkers are establishing novel hallmarks in diseases, in several cases for early diagnostics of diseases and discovery of drug targets in the proteins involved in the mechanical changes, while advances in instrumentation are bringing commercial products into the clinical practice. Mechanical biomarkers along with clinical testing are establishing an important niche in the market, whose demand is increasing due to the expansion of personalized medicine and unmet needs in the clinics. [ABSTRACT FROM AUTHOR]
Published: 2023
Full Text: View/download PDF

6. Molecular Beacon for Detection miRNA-21 as a Biomarker of Lung Cancer

Author: Daniela Alexandre, Bernardo Teixeira, André Rico, Salete Valente, Ana Craveiro, Pedro V. Baptista, Carla Cruz, DCV - Departamento de Ciências da Vida, and UCIBIO - Applied Molecular Biosciences Unit
Subjects: Lung Neoplasms, Organic Chemistry, General Medicine, lung cancer, diagnosis, microRNAs, peripheral blood mononuclear cells, molecular beacon, Catalysis, Computer Science Applications, Inorganic Chemistry, Gene Expression Regulation, Neoplastic, MicroRNAs, SDG 3 - Good Health and Well-being, Peripheral blood mononuclear cells, Carcinoma, Non-Small-Cell Lung, Diagnosis, Biomarkers, Tumor, Leukocytes, Mononuclear, Humans, Lung cancer, Physical and Theoretical Chemistry, Molecular Biology, Molecular beacon, Spectroscopy
Abstract: Funding Information: Funding: This work is financed by FCT—Fundação para a Ciência e a Tecnologia, I.P., project CICS-UBI UIDP/00709/2020. Also the authors acknowledge projects UIDB/00709/2020, UID/Multi/04349/ 2019, POCI-01-0145-FEDER-022122 research unit PPBI-Portuguese Platform of BioImaging and Portuguese NMR Network (ROTEIRO/0031/2013-PINFRA/22161/2016), UIDP/04378/2020 and UIDB/04378/2020 of the Research Unit on Applied Molecular Biosciences—UCIBIO and the project LA/P/0140/2020 of the Associate Laboratory Institute for Health and Bioeconomy—i4HB. Funding Information: Acknowledgments: Daniela Alexandre acknowledges the FCT fellowship ref. 2021.07695.BD. Publisher Copyright: © 2022 by the authors. Licensee MDPI, Basel, Switzerland. Lung cancer (LC) is the leading cause of cancer-related death worldwide. Although the diagnosis and treatment of non-small cell lung cancer (NSCLC), which accounts for approximately 80% of LC cases, have greatly improved in the past decade, there is still an urgent need to find more sensitive and specific screening methods. Recently, new molecular biomarkers are emerging as potential non-invasive diagnostic agents to screen NSCLC, including multiple microRNAs (miRNAs) that show an unusual expression profile. Moreover, peripheral blood mononuclear cells’ (PBMCs) miRNA profile could be linked with NSCLC and used for diagnosis. We developed a molecular beacon (MB)-based miRNA detection strategy for NSCLC. Following PBMCs isolation and screening of the expression profile of a panel of miRNA by RT-qPCR, we designed a MB targeting of up-regulated miR-21-5p. This MB 21-5p was characterized by FRET-melting, CD, NMR and native PAGE, allowing the optimization of an in-situ approach involving miR-21-5p detection in PBMCs via MB. Data show the developed MB approach potential for miR-21-5p detection in PBMCs from clinical samples towards NSCLC. publishersversion published
Published: 2022

7. Effect of Spatiotemporal Parameters on the Gait of Children Aged from 6 to 12 Years in Podiatric Tests: A Cross Sectional Study.

Author: Martinez-Rico, Magdalena, Ortega-Avila, Ana Belen, Pineda-Galan, Consolacion, Gijon-Nogueron, Gabriel, Pardo Rios, Manuel, Alabua-Dasi, Raquel, and Marchena-Rodriguez, Ana
Subjects: SCIENTIFIC observation, GAIT in humans, CROSS-sectional method, FUNCTIONAL status, PODIATRY, LEG, DIAGNOSIS, BODY movement, DESCRIPTIVE statistics, BIOMECHANICS, DATA analysis software, SPACE perception, KINEMATICS
Abstract: The use of lower limb tests in the paediatric population is of great importance for diagnostic evaluations. The aim of this study is to understand the relationship between the tests performed on the feet and ankles, covering all of its planes, and the spatiotemporal parameters of children's gait. Methods: It is a cross-sectional observational study. Children aged between 6 and 12 years participated. Measurements were carried out in 2022. An analysis of three tests used to assess the feet and ankles (FPI, the ankle lunge test, and the lunge test), as well as a kinematic analysis of gait using OptoGait as a measurement tool, was performed. Results: The spatiotemporal parameters show how Jack's Test is significant in the propulsion phase in its % parameter, with a p-value of 0.05 and a mean difference of 0.67%. Additionally, in the lunge test, we studied the % of midstance in the left foot, with a mean difference between the positive test and the 10 cm test of 10.76 (p value of 0.04). Conclusions: The diagnostic analysis of the functional limitation of the first toe (Jack's test) is correlated with the spaciotemporal parameter of propulsion, as well as the lunge test, which is also correlated with the midstance phase of gait. [ABSTRACT FROM AUTHOR]
Published: 2023
Full Text: View/download PDF

8. Cardiovascular Screening Practices and Statin Prescription Habits in Patients with Psoriasis among Dermatologists, Rheumatologists and Primary Care Physicians.

Author: BERNA-RICO, Emilio, DE ARAGON, Carlota ABBAD-JAIME, GARCIA-APARICIO, Ángel, PALACIOS-MARTINEZ, David, BALLESTER-MARTÍNEZ, Asunción, CARRASCOSA, Jose-M, DE LA CUEVA, Pablo, ANTON, Cristina, AZCARRAGALLOBET, Carlos, GARCIA-MOURONTE, Emilio, DE NICOLAS-RUANES, Belén, PUIG, Lluis, JAEN, Pedro, MEHTA, Nehal N., GELFAND, Joel M., and GONZALEZ-CANTERO, Álvaro
Subjects: *PHYSICIANS, *MEDICAL screening, *PRIMARY care, *RHEUMATOLOGISTS, *DERMATOLOGISTS
Abstract: Patients with psoriasis have a higher prevalence of cardiovascular risk factors. This study evaluated cardiovascular screening practices and statin prescribing habits among dermatologists, rheumatologists and primary care physicians (PCPs) through an online questionnaire, which was distributed through the Spanish scientific societies of the above-mentioned specialties. A total of 299 physicians (103 dermatologists, 94 rheumatologists and 102 PCPs) responded to the questionnaire. Of these, 74.6% reported screening for smoking, 37.8% for hypertension, 80.3% for dyslipidaemia, and 79.6% for diabetes mellitus. Notably, only 28.4% performed global screening, defined as screening for smoking, hypertension, dyslipidaemia, and diabetes mellitus by the same physician, and 24.4% reported calculating 10-year cardiovascular disease (CVD) risk, probably reflecting a lack of comprehensive cardiovascular risk assessment in these patients. This study also identified unmet needs for awareness of cardiovascular comorbidities in psoriasis and corresponding screening and treatment recommendations among PCPs. Of PCPs, 61.2% reported not being aware of the association between psoriasis and CVD and/or not being aware of its screening recommendations, and 67.6% did not consider psoriasis as a risk-enhancing factor when deciding on statin prescription. Thirteen dermatologists (12.6%) and 35 rheumatologists (37.2%) reported prescribing statins. Among those who do not prescribe, 49.7% would be willing to start their prescription. [ABSTRACT FROM AUTHOR]
Published: 2023
Full Text: View/download PDF

9. Desequilibrio ácido-base: una revisión con el algoritmo de diagnóstico unificado propuesto

Author: José Correa Guerrero, Jorge Rico Fontalvo, Rodrigo Daza Arnedo, Emilio Abuabara Franco, Victor Leal Martínez, Nehomar Eduardo Pájaro Galvis, María Cardona Blanco, María Monterrosa Robles, Jenniffer Palomino Herrera, Mauricio Batista Lambis, Isaias Garcerant Campo, Ronald Castro Ahumada, and Karen Perales Caballero
Subjects: acid-baseimbalance, lcsh:Internal medicine, algorithms(mesh), diagnosis, bloodgasanalysis, lcsh:RC31-1245, lcsh:Diseases of the genitourinary system. Urology, lcsh:RC870-923
Abstract: la incorporación de las tres teorías en un algoritmo diagnóstico facilita una mayor comprensión de los mecanismos fisiopatológicos y permite identificar un objetivo terapéutico más preciso para corregir el trastorno de base en los diferentes contextos clínicos del paciente
Published: 2020

10. Detecting SARS‐CoV‐2 RNA in conjunctival secretions: Is it a valuable diagnostic method of COVID‐19?

Author: Alberto Delgado-Iribarren, Ricardo Cuiña-Sardiña, Barbara Burgos-Blasco, Julian Garcia-Feijoo, Pedro Arriola-Villalobos, Carla M. Rico‐Luna, Noemi Güemes-Villahoz, and Ana Arribi-Vilela
Subjects: Adult, Male, Bodily Secretions, medicine.medical_specialty, Diagnostic methods, Coronavirus disease 2019 (COVID-19), diagnosis, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), coronavirus, medicine.disease_cause, Specimen Handling, Conjunctivitis, Viral, 03 medical and health sciences, 0302 clinical medicine, Virology, conjunctivitis, medicine, Humans, Viral rna, 030212 general & internal medicine, Research Articles, Aged, COVID, Coronavirus, Aged, 80 and over, business.industry, Transmission (medicine), COVID-19, RNA, Middle Aged, Dermatology, Cross-Sectional Studies, PCR, Infectious Diseases, Spain, Conjunctival swab (specimen), RNA, Viral, Female, 030211 gastroenterology & hepatology, business, Conjunctiva, Research Article
Abstract: The main purpose of this study is to evaluate the presence of viral RNA of severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) in conjunctival swab specimen of coronavirus disease 2019 (COVID‐19) patients with and without conjunctivitis to establish the diagnostic value of reverse transcription‐polymerase chain reaction (RT‐PCR) in each case and to describe its clinical characteristics. A cross‐sectional study was conducted at the Hospital Clinico San Carlos of Madrid, Spain. Thirty‐six subjects from the COVID admission unit with laboratory‐confirmed SARS‐CoV‐2 infection were included. Conjunctival swabs were collected from 18 patients with conjunctivitis and 18 patients without conjunctivitis and RT‐PCR was performed. Conjunctival swab was collected from both eyes of 36 patients (72 eyes), detecting SARS‐CoV‐2 RNA in conjunctival swab of two patients (5.5%). Among the 18 patients with conjunctivitis, only one of them (5.5%) showed positive results. Likewise, SARS‐CoV‐2 RNA was detected in one patient without conjunctivitis (5.5%). The mean age of the 36 patients was 67.9 years (range, 28‐92 years) and the male‐to‐female ratio was 0.44 (16:20). The mean days since the onset of COVID‐19 symptoms until conjunctivitis manifestation was 8 (range, 1‐24 days). The mean duration of the conjunctivitis was 3 days (range, 1‐7 days). SARS‐CoV‐2 RNA may be detected in conjunctival swabs of both patients with and without conjunctivitis. This study revealed the same rate of positive results amongst the group with and without conjunctivitis, suggesting that detecting SARS‐CoV‐2 in ocular fluids is not conditioned on the presence of conjunctivitis. The presence of SARS‐CoV‐2 RNA in ocular samples highlights the role of the eye as a possible route of transmission of the disease., Highlights SARS‐CoV‐2 RNA can be detected in conjunctival secretions of both patients with and without conjunctivitis. However, PCR essay of tears and conjunctival secretions appear to have a fairly low potential of detecting the virus.
Published: 2020

11. Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score

Author: Juan Salillas, Miguel Fernández Huerta, Patricio González-Pizarro, Francisco Javier Membrillo, Raul Galera, Jesús Rodríguez-Baño, Lydia Galvez, Juan Cuadros-González, Aina Gabarrell-Pascuet, Jorge Diaz-Garzon, INMA JARRIN, Claudia González-Rico, Alicia Rico Nieto, Cristina Cervera, Carlos Bea Serrano, Alberto Ouro Villasante, Guillermo Ruiz-Carrascoso, Beatriz Díaz-Pollán, María del mar Arcos Rueda, Julio Garcia-Rodriguez, BELEN GUTIÉRREZ-GUTIÉRREZ, MARCO ANTONIO SEMPERE ALCOCER, Cristina Verdú Sánchez, Lucía Hernández-Rivas, Guillermo Cuervo, Alejandro Smithson, Miguel Torralba, Iván Bloise, Alexander Rombauts, Carlos Toro, Lucio Jesus García-Fraile Fraile, Alejandro García-Ruiz de Morales, Cecilia Tortajada, KAPIL LAXMAN NANWANI NANWANI, Lorena De la Mora Cañizo, Laia Lorenzo-Esteller, Jorge Álvarez Troncoso, Cristina Roca Oporto, Alejandro Martin-Quiros, José A. Oteo, Eduardo Malmierca Corral, Stefan Stewart, Jerónimo Pachón, Almudena Gutiérrez-Arroyo, Moreno-Cuerda Victor, Carlos Carpio, Emilio Cendejas-Bueno, Pilar Fernandez-Calle, Antonio Javier Carcas Sansuán, Alexy Inciarte, Pablo Ryan, Luis Puente-Maestu, Jesús Troya García, Francisco de Asís Alcántara Nicolás, Gabriela Abelenda-Alonso, Natividad Benito, Daniel Prieto Arribas, Jesus Mingorance, Jose L Del Pozo, Jordi Carratala, Cristina Marcelo, Marta Ruiz-Algueró, Sarah CARO BRAGADO, Juan Berenguer, Vicens Diaz-Brito, Víctor Hontañón Antoñana, Julen Cadiñanos, Jose Arribas, María Jesús Jaras Hernández, Henar Calvo Sánchez, Elisa Cordero, Instituto de Salud Carlos III, Fundación Seimc-Gesida, Plan Nacional de I+D+i (España), Ministerio de Ciencia y Universidades (España), Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF), Red de Investigación Cooperativa en Investigación en Sida (España), Red de Investigación Cooperativa en Investigación en Patología Infecciosa (España), Fundación SEIMC-GESIDA, Ministerio de Ciencia, Innovación y Universidades (España), European Commission, Red Española de Investigación en SIDA, Red Española de Investigación en Patología Infecciosa, Universidad de Cantabria, UAM. Departamento de Farmacología, and UAM. Departamento de Medicina
Subjects: Male, Neutrophils, Respiratory Infection, 030204 cardiovascular system & hematology, Logistic regression, 0302 clinical medicine, Diagnòstic, Risk Factors, Respiratory infection, Diagnosis, Epidemiology, 030212 general & internal medicine, Hospital Mortality, Aged, 80 and over, Prediction theory, Age Factors, clinical epidemiology, Middle Aged, Tool, Emergency medicine, Female, Glomerular Filtration Rate, Pulmonary and Respiratory Medicine, Adult, Prognostic variable, medicine.medical_specialty, Medicina, Renal function, Diagnosis tripod, 03 medical and health sciences, Sex Factors, emergency medicine, Internal medicine, medicine, pneumonia, Humans, Derivation, Lymphocyte Count, Aged, Inpatients, Receiver operating characteristic, business.industry, SARS-CoV-2, Clinical epidemiology, COVID-19, Pneumonia, medicine.disease, Individual prognosis, critical care, Oxygen, Critical care, Logistic Models, Dyspnea, ROC Curve, Teoria de la predicció, Viral infection, viral infection, business, Kidney disease
Abstract: COVID-19@Spain and COVID@HULP Study., [Objective] To develop and validate a prediction model of mortality in patients with COVID-19 attending hospital emergency rooms., [Design] Multivariable prognostic prediction model., [Setting] 127 Spanish hospitals., [Participants] Derivation (DC) and external validation (VC) cohorts were obtained from multicentre and single-centre databases, including 4035 and 2126 patients with confirmed COVID-19, respectively., [Interventions] Prognostic variables were identified using multivariable logistic regression., [Main outcome measures] 30-day mortality., [Results] Patients’ characteristics in the DC and VC were median age 70 and 61 years, male sex 61.0% and 47.9%, median time from onset of symptoms to admission 5 and 8 days, and 30-day mortality 26.6% and 15.5%, respectively. Age, low age-adjusted saturation of oxygen, neutrophil-to-lymphocyte ratio, estimated glomerular filtration rate by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation, dyspnoea and sex were the strongest predictors of mortality. Calibration and discrimination were satisfactory with an area under the receiver operating characteristic curve with a 95% CI for prediction of 30-day mortality of 0.822 (0.806–0.837) in the DC and 0.845 (0.819–0.870) in the VC. A simplified score system ranging from 0 to 30 to predict 30-day mortality was also developed. The risk was considered to be low with 0–2 points (0%–2.1%), moderate with 3–5 (4.7%–6.3%), high with 6–8 (10.6%–19.5%) and very high with 9–30 (27.7%–100%)., [Conclusions] A simple prediction score, based on readily available clinical and laboratory data, provides a useful tool to predict 30-day mortality probability with a high degree of accuracy among hospitalised patients with COVID-19., This work was supported by Fundación SEIMC/GeSIDA. The funders had no role in study design, data collection, data interpretation or writing of the manuscript. JB, JRB, IJ, JC, JP and JRA received funding for research from Plan Nacional de I+D+i 2013‐2016 and Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Ciencia, Innovación y Universidades, cofinanced by the European Development Regional Fund “A way to achieve Europe”, Operative program Intelligent Growth 2014‐2020. Spanish AIDS Research Network (RIS) (RD16/0025/0017 (JB), RD16/0025/0018 (JRA), RD16CIII/0002/0006 (IJ)). Spanish Network for Research in Infectious Diseases (REIPI) (RD16/0016/0001 (JRB), RD16/0016/0005 (JC) and RD16/0016/0009 (JP)).
Published: 2021

12. Opportunities and challenges for newborn screening and early diagnosis of rare diseases in Latin America.

Author: Giugliani, Roberto, Taucher, Silvia Castillo, Hafez, Sylvia, Oliveira, Joao Bosco, Rico-Restrepo, Mariana, Rozenfeld, Paula, Zarante, Ignacio, and Gonzaga-Jauregui, Claudia
Subjects: NEWBORN screening, DIAGNOSIS, RARE diseases, EARLY diagnosis, MEDICAL societies
Abstract: Rare diseases (RDs) cause considerable death and disability in Latin America. Still, there is no consensus on their definition across the region. Patients with RDs face a diagnostic odyssey to find a correct diagnosis, which may last many years and creates a burden for caregivers, healthcare systems, and society. These diagnostic delays have repercussions on the health and economic burden created by RDs and continue to represent an unmet medical need. This review analyzes barriers to the widespread adoption of newborn screening (NBS) programs and early diagnostic methods for RDs in Latin America and provides recommendations to achieve this critical objective. Increasing the adoption of NBS programs and promoting early diagnosis of RDs are the first steps to improving health outcomes for patients living with RDs. A coordinated, multistakeholder effort from leaders of patient organizations, government, industry, medical societies, academia, and healthcare services is required to increase the adoption of NBS programs. Patients' best interests should remain the guiding principle for decisions regarding NBS implementation and early diagnosis for RDs. [ABSTRACT FROM AUTHOR]
Published: 2022
Full Text: View/download PDF

13. Biomarker Discovery for Meta-Classification of Melanoma Metastatic Progression Using Transfer Learning.

Author: Miñoza, Jose Marie Antonio, Rico, Jonathan Adam, Zamora, Pia Regina Fatima, Bacolod, Manny, Laubenbacher, Reinhard, Dumancas, Gerard G., and de Castro, Romulo
Subjects: *PROGNOSIS, *MELANOMA, *SKIN cancer, *DIAGNOSIS, *MACHINE learning, *BIOMARKERS
Abstract: Melanoma is considered to be the most serious and aggressive type of skin cancer, and metastasis appears to be the most important factor in its prognosis. Herein, we developed a transfer learning-based biomarker discovery model that could aid in the diagnosis and prognosis of this disease. After applying it to the ensemble machine learning model, results revealed that the genes found were consistent with those found using other methodologies previously applied to the same TCGA (The Cancer Genome Atlas) data set. Further novel biomarkers were also found. Our ensemble model achieved an AUC of 0.9861, an accuracy of 91.05, and an F1 score of 90.60 using an independent validation data set. This study was able to identify potential genes for diagnostic classification (C7 and GRIK5) and diagnostic and prognostic biomarkers (S100A7, S100A7, KRT14, KRT17, KRT6B, KRTDAP, SERPINB4, TSHR, PVRL4, WFDC5, IL20RB) in melanoma. The results show the utility of a transfer learning approach for biomarker discovery in melanoma. [ABSTRACT FROM AUTHOR]
Published: 2022
Full Text: View/download PDF

14. Management of acquired hemophilia A: results from the Spanish registry

Author: Mingot Castellano, María Eva, Pardos Gea, Josep, Haya, Saturnino, Bastida Bermejo, José María, Tàssies, Dolors, Marco Rico, Ana, Núñez, Ramiro, García Candel, Faustino, Fernández Sánchez de Mora, María Carmen, Soto, Inmaculada, Álvarez Román, María Teresa, Asenjo, Susana, Carrasco, Marina (Carrasco Pérez), Lluch García, Rafael, Martín Antorán, José Manuel, Rodríguez Alén, Agustín, Roselló, Elena, Torres Miñana, Laura, Marcellini Antonio, Shally, Moretó Quinana, Ana, Rodríguez García, José Antonio, Aguinaco Culebras, Reyes, Alonso Escobar, Nieves, Cervero Santiago, Carlos, Fernández Mosteirín, Núria, Martínez Badás, María Paz, Pérez Sánchez, Montserrat, Pérez Montes, Rocío, Rodríguez González, Ramón, Uribe Barrientos, Marisol, Caparrós Miranda, Isabel Socorro, Iglesias Fernández, Miriam, Baena, Ángela, Rodríguez López, Manuel, Sebrango Sandia, Ana, Vázquez Fernández, Irene, Marco, Pascual, and Spanish Society of Thrombosis and Haemostasis (SETH)
Subjects: Male, medicine.medical_specialty, Cyclophosphamide, BLEEDING EPISODES, FRANCE, Hemophilia A, DIAGNOSIS, Thrombosis and Hemostasis, Hemofília, Internal medicine, Antithrombotic, SURVEILLANCE, Medicine, Humans, HEMOSTASIS, Registries, Espanya, Hemophilia, Aged, Autoantibodies, Retrospective Studies, Factor VIII, business.industry, Autoantibody, Retrospective cohort study, Hematology, Calcineurin, Spain, Acquired hemophilia, Rituximab, Female, business, Fibrinolytic agent, medicine.drug
Abstract: The Spanish Acquired Hemophilia A (AHA) Registry is intended to update the status of AHA in Spain. One hundred and fifty-four patients were included and retrospectively followed for a median of 12 months. Patients were predominantly male (56.3%), with median age at diagnosis of 74 years. AHA was more frequently idiopathic (44.1%) and autoimmune disorder-associated (31.7%). Thirty-four percent of patients were on antithrombotic therapy at diagnosis. Hemostatic treatment was used in 70% of patients. Recombinant activated factor VII was more frequently infused (60.3% vs 20.6% activated prothrombin complex concentrate). Only 1 patient did not achieve control of hemorrhage. Complete remission (CR) was achieved by 84.2% of cases after immunosuppressive therapy. Steroids alone were less efficient than the other strategies (68.2% vs 87.2%, P = .049), whereas no differences existed among these (steroids/cyclophosphamide, 88.5%, vs steroids/calcineurin inhibitors, 81.2%, vs rituximab-based regimens, 87.5%). Female sex and high inhibitor levels influenced CR negatively. Thirty-six deaths (23.8%) were reported. Main causes of death were infection (15 patients, 9.9%) and hemorrhage (5 patients, 3.3%). All hemorrhage-related and half the infection-related deaths occurred within 2 months of diagnosis. Prior antithrombotic therapy was inversely associated with survival, irrespective of age. Median age of nonsurvivors was significantly higher (79 vs 73 years in survivors). Patients dying of infection were older than the other nonsurvivors (85 vs 78 years). In summary, fatal infection in the first months is common in our series. Antithrombotic therapy is associated with mortality. Particular care should be taken to avoid misdiagnosis.
Published: 2021

15. Clinical presentation, aetiology and outcomes of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study

Author: Habib G., Erba P. A., Iung B., Donal E., Cosyns B., Laroche C., Popescu B. A., Prendergast B., Tornos P., Sadeghpour A., Oliver L., Vaskelyte J. -J., Sow R., Axler O., Maggioni A. P., Lancellotti P, C P Gale, B Beleslin, A Budaj, O Chioncel, N Dagres, N Danchin, J Emberson, D Erlinge, M Glikson, A Gray, M Kayikcioglu, A P Maggioni, V K Nagy, A Nedoshivin, A-S Petronio, J Roos-Hesselink, L Wallentin, U Zeymer, G Habib, P Lancellotti, B Cosyns, E Donal, P Erba, B Iung, B A Popescu, B Prendergast, P Tornos, M Andarala, C Berle, A Brunel-Lebecq, E Fiorucci, C Laroche, V Missiamenou, C Taylor, N N Ali Tatar-Chentir, M Al-Mallah, M Astrom Aneq, G Athanassopoulos, L P Badano, S Benyoussef, E Calderon Aranda, N M Cardim, K-L Chan, I Cruz, T Edvardsen, G Goliasch, A Hagendorff, K Hristova, O Kamp, D-H Kang, W Kong, S Matskeplishvili, M Meshaal, M Mirocevic, A N Neskovic, M Pazdernik, E Plonska-Gosciniak, M Raissouni, R Ronderos, L E Sade, A Sadeghpour, A Sambola, S Sengupta, J Separovic-Hanzevacki, M Takeuchi, E Tucay, A C Tude Rodrigues, A Varga, J Vaskelyte, K Yamagata, K Yiangou, H Zaky, I Granada, M Mahia, S Ressi, F Nacinovich, A Iribarren, P Fernandez Oses, G Avegliano, E Filipini, R Obregon, M Bangher, J Dho, L Cartasegna, M L Plastino, V Novas, C Shigel, G Reyes, M De Santos, N Gastaldello, M Granillo Fernandez, M Potito, G Streitenberger, P Velazco, J H Casabé, C Cortes, E Guevara, F Salmo, M Seijo, F Weidinger, M Heger, R Brooks, C Stöllberger, C-Y Ho, L Perschy, L Puskas, C Binder, R Rosenhek, M Schneider, M-P Winter, E Hoffer, M Melissopoulou, E Lecoq, D Legrand, S Jacquet, M Massoz, L Pierard, S Marchetta, R Dulgheru, C D Emal, C Oury, S Droogmans, D Kerkhove, D Plein, L Soens, C Weytjens, A Motoc, B Roosens, I Lemoine, I Rodrigus, B Paelinck, B Amsel, P Unger, D Konopnicki, C Beauloye, A Pasquet, J L Vanoverschelde, S Pierard, D Vancraeynest, F Sinnaeve, J L Andrade, K Staszko, R Dos Santos Monteiro, M H Miglioranza, D L Shuha, M Alcantara, V Cravo, L Fazzio, A Felix, M Iso, C Musa, A P Siciliano, F Villaca Filho, A Rodrigues, F Vilela, J Braga, R Silva, D Rodrigues, L Silva, S Morhy, C Fischer, M Vieira, T Afonso, J Abreu, S N Falcao, V A Moises, A Gouvea, F J Mancuso, A C Souza, C Y Silva, G João, C S Abboud, R Bellio de Mattos Barretto, A Ramos, R Arnoni, J E Assef, D J Della Togna, D Le Bihan, L Miglioli, A P Romero Oliveira, R Tadeu Magro Kroll, D Cortez, C L Gelape, M D C Peirira Nunes, T C De Abreu Ferrari, K Hay, V Le, M Page, F Poulin, C Sauve, K Serri, C Mercure, J Beaudoin, P Pibarot, I A Sebag, L G Rudski, G Ricafort, B Barsic, V Krajinovic, M Vargovic, D Lovric, V Reskovic-Luksic, J Vincelj, S Jaksic Jurinjak, V Yiannikourides, M Ioannides, C Pofaides, V Masoura, J Pudich, A Linhart, M Siranec, J Marek, K Blechova, M Kamenik, R Pelouch, Z Coufal, M Mikulica, M Griva, E Jancova, M Mikulcova, M Taborsky, J Precek, M Jecmenova, J Latal, J Widimsky, T Butta, S Machacek, R Vancata, J Spinar, M Holicka, F Pow Chon Long, N Anzules, A Bajana Carpio, G Largacha, E Penaherrera, D Moreira, E Mahfouz, E Elsafty, A Soliman, Y Zayed, J Aboulenein, M Abdel-Hay, A Almaghraby, M Abdelnaby, M Ahmed, B Hammad, Y Saleh, H Zahran, O Elgebaly, A Saad, M Ali, A Zeid, R El Sharkawy, A Al Kholy, R Doss, D Osama, H Rizk, A Elmogy, M Mishriky, P Assayag, S El Hatimi, S Hubert, J-P Casalta, F Gouriet, F Arregle, S Cammilleri, L Tessonnier, A Riberi, E Botelho-Nevers, A Gagneux-Brunon, R Pierrard, C Tulane, S Campisi, J-F Fuzellier, M Detoc, T Mehalla, D Boutoille, A S Lecompte, M Lefebvre, S Pattier, O Al Habash, N Asseray-Madani, C Biron, J Brochard, J Caillon, C Cueff, T Le Tourneau, R Lecomte, M M Magali Michel, J Orain, S Delarue, M Le Bras, J-F Faucher, V Aboyans, A Beeharry, H Durox, M Lacoste, J Magne, D Mohty, A David, V Pradel, V Sierra, A Neykova, B Bettayeb, S Elkentaoui, B Tzvetkov, G Landry, C Strady, K Ainine, S Baumard, C Brasselet, C Tassigny, V Valente-Pires, M Lefranc, B Hoen, B Lefevre, E Curlier, C Callier, N Fourcade, Y Jobic, S Ansard, R Le Berre, F Le Ven, M-C Pouliquen, G Prat, P Le Roux, F Bouchart, A Savoure, C Alarcon, C Chapuzet, I Gueit, C Tribouilloy, Y Bohbot, F Peugnet, M Gun, X Duval, X Lescure, E Ilic-Habensus, N Sadoul, C Selton-Suty, F Alla, F Goehringer, O Huttin, E Chevalier, R Garcia, V Le Marcis, P Tattevin, E Flecher, M Revest, C Chirouze, K Bouiller, L Hustache-Mathieu, T Klopfenstein, J Moreau, D Fournier, A-S Brunel, P Lim, L Oliver, J Ternacle, A Moussafeur, P Chavanet, L Piroth, A Salmon-Rousseau, M Buisson, S Mahy, C Martins, S Gohier, O Axler, F Baumann, S Lebras, C Piper, D Guckel, J Börgermann, D Horstkotte, E Winkelmann, B Brockmeier, D Grey, G Nickenig, R Schueler, C Öztürk, E Stöhr, C Hamm, T Walther, R Brandt, A-C Frühauf, C T Hartung, C Hellner, C Wild, M Becker, S Hamada, W Kaestner, K Stangl, F Knebel, G Baldenhofer, A Brecht, H Dreger, C Isner, F Pfafflin, M Stegemann, R Zahn, B Fraiture, C Kilkowski, A-K Karcher, S Klinger, H Tolksdorf, D Tousoulis, C Aggeli, S Sideris, E Venieri, G Sarri, D Tsiapras, I Armenis, A Koutsiari, G Floros, C Grassos, S Dragasis, L Rallidis, C Varlamos, L Michalis, K Naka, A Bechlioulis, A Kotsia, L Lakkas, K Pappas, C Papadopoulos, S Kiokas, A Lioni, S Misailidou, J Barbetseas, M Bonou, C Kapelios, I Tomprou, K Zerva, A Manolis, E Hamodraka, D Athanasiou, G Haralambidis, H Samaras, L Poulimenos, A Nagy, A Bartykowszki, E Gara, K Mungulmare, R Kasliwal, M Bansal, S Ranjan, A Bhan, M Kyavar, M Maleki, F Noohi Bezanjani, A Alizadehasl, S Boudagh, A Ghavidel, P Moradnejad, H R Pasha, B Ghadrdoost, D Gilon, J Strahilevitz, M Wanounou, S Israel, C d'Agostino, P Colonna, L De Michele, F Fumarola, M Stante, N Marchionni, V Scheggi, B Alterini, S Del Pace, P Stefano, C Sparano, N Ruozi, R Tenaglia, D Muraru, U Limbruno, A Cresti, P Baratta, M Solari, C Giannattasio, A Moreo, B De Chiara, B Lopez Montero, F Musca, C A Orcese, F Panzeri, F Spano, C F Russo, O Alfieri, M De Bonis, S Chiappetta, B Del Forno, M Ripa, P Scarpellini, C Tassan Din, B Castiglioni, R Pasciuta, S Carletti, D Ferrara, M Guffanti, G Iaci, E Lapenna, T Nisi, C Oltolini, E Busnardo, U Pajoro, E Agricola, R Meneghin, D Schiavi, F Piscione, R Citro, R M Benvenga, L Greco, L Soriente, I Radano, C Prota, M Bellino, D Di Vece, F Santini, A Salsano, G M Olivieri, F Turrini, R Messora, S Tondi, A Olaru, V Agnoletto, L Grassi, C Leonardi, S Sansoni, S Del Ponte, G M Actis Dato, A De Martino, N Ohte, S Kikuchi, K Wakami, K Aonuma, Y Seo, T Ishizu, T Machino-Ohtsuka, M Yamamoto, N Iida, H Nakajima, Y Nakagawa, C Izumi, M Amano, M Miyake, K Takahashi, I Shiojima, Y Miyasaka, H Maeba, Y Suwa, N Taniguchi, S Tsujimoto, T Kitai, M Ota, S Yuda, S Sasaki, N Hagiwara, K Yamazaki, K Ashihara, K Arai, C Saitou, S Saitou, G Suzuki, Y Shibata, N Watanabe, S Nishino, K Ashikaga, N Kuriyama, K Mahara, T Okubo, H Fujimaki, H Shitan, H Yamamoto, K Abe, M Terada, S Takanashi, M Sata, H Yamada, K Kusunose, Y Saijo, H Seno, O Yuichiro, T Onishi, F Sera, S Nakatani, H Mizuno, K Sengoku, S W Park, K Eun Kyoung, L Ga Yeon, J-W Hwang, C Jin-Oh, S-J Park, L Sang-Chol, C Sung-A, S Y Jang, R Heo, S Lee, J-M Song, E Jung, J Plisiene, A Dambrauskaite, G Gruodyte, R Jonkaitiene, V Mizariene, J Atkocaityte, R Zvirblyte, R Sow, A Codreanu, T Staub, C Michaux, E C L De la Vega, L Jacobs-Orazi, C Mallia Azzopardi, R G Xuereb, T Piscopo, J Farrugia, M Fenech, E Pllaha, C Vella, D Borg, R Casha, L Grib, E Raevschi, A Grejdieru, D Kravcenco, E Prisacari, E Samohvalov, S Samohvalov, N Sceglova, E Panfile, L Cardaniuc, V Corcea, A Feodorovici, V Gaina, L Girbu, P Jimbei, G Balan, I Cardaniuc, I Benesco, V Marian, N Sumarga, B Bozovic, N Bulatovic, P Lakovic, L Music, R Budde, A Wahadat, T Gamela, T Meijers, J P Van Melle, V M Deursen, H J Crijns, S C Bekkers, E C Cheriex, M Gilbers, B L Kietselaer, C Knackstedt, R Lorusso, S Schalla, S A Streukens, S Chamuleau, M-J Cramer, A Teske, T Van der Spoel, A Wind, J Lokhorst, O Liesbek, H Van Heusden, W Tanis, I Van der Bilt, J Vriend, H De Lange-van Bruggen, E Karijodikoro, R Riezebos, E van Dongen, J Schoep, V Stolk, J T Offstad, J O Beitnes, T Helle-Valle, H Skulstad, R Skardal, N Qamar, S Furnaz, B Ahmed, M H Butt, M F Khanzada, T Saghir, A Wahid, T Hryniewiecki, P Szymanski, K Marzec, M Misztal-Ogonowska, W Kosmala, M Przewlocka-Kosmala, A Rojek, K Woznicka, J Zachwyc, A Lisowska, M Kaminska, J D Kasprzak, E Kowalczyk, D F Strzecka, P Wejner-Mik, M Trabulo, P Freitas, S Ranchordas, G Rodrigues, P Pinto, C Queiros, J Azevedo, L Marques, D Seabra, L Branco, M Cruz, A Galrinho, R Moreira, P Rio, A T Timoteo, M Selas, V Carmelo, B Duque Neves, H Pereira, A Guerra, A Marques, I Pintassilgo, M C Tomescu, N-M Trofenciuc, M Andor, A Bordejevic, H S Branea, F Caruntu, L A Velcean, A Mavrea, M F Onel, T Parvanescu, D Pop, A L Pop-Moldovan, M I Puticiu, L Cirin, I M Citu, C A Cotoraci, D Darabantiu, R Farcas, I Marincu, A Ionac, D Cozma, C Mornos, F Goanta, I Popescu, R Beyer, R Mada, R Rancea, R Tomoaia, H Rosianu, C Stanescu, Z Kobalava, J Karaulova, E Kotova, A Milto, A Pisaryuk, N Povalyaev, M Sorokina, J Alrahimi, A Elshiekh, A Jamiel, A Ahmed, N Attia, B Putnikovic, A Dimic, B Ivanovic, S Matic, D Trifunovic, J Petrovic, D Kosevic, I Stojanovic, I Petrovic, P Dabic, P Milojevic, I Srdanovic, S Susak, L Velicki, A Vulin, M Kovacevic, A Redzek, M Stefanovic, T C Yeo, W Kf Kong, K K Poh, I Vilacosta, C Ferrera, C Olmos, M Abd El-Nasser, F Calvo Iglesias, E Blanco-Gonzalez, M Bravo Amaro, E Lopez-Rodriguez, J Lugo Adan, A N Germinas, P Pazos-Lopez, M Pereira Loureiro, M T Perez, S Raposeiras-Roubin, S Rasheed Yas, M-M Suarez-Varela, F Vasallo Vidal, D Garcia-Dorado, N Fernandez-Hidalgo, T Gonzalez-Alujas, J Lozano, O Maisterra, N Pizzi, R Rios, A Bayes-Genis, L Pedro Botet, N Vallejo, C Llibre, L Mateu, R Nunez, D Quesada, E Berastegui, D Bosch Portell, J Aboal Vinas, X Albert Bertran, R Brugada Tarradellas, P Loma-Osorio Ricon, C Tiron de Llano, M A Arnau, A Bel, M Blanes, A Osa, M Anguita, F Carrasco, J C Castillo, J L Zamorano, J L Moya Mur, M Alvaro, C Fernandez-Golfin, J M Monteagudo, E Navas Elorza, M C Farinas Alvarez, J Aguero Balbin, J Zarauza, J F Gutierrez-Diez, C Arminanzas, F Arnaiz de Las Revillas, A Arnaiz Garcia, M Cobo Belaustegui, M Fernandez Sampedro, M Gutierrez Cuadra, L Garcia Cuello, C Gonzalez Rico, R Rodriguez-Alvarez, J Goikoetxea, M Montejo, J M Miro, M Almela, J Ambrosioni, A Moreno, E Quintana, E Sandoval, A Tellez, J M Tolosana, B Vidal, C Falces, D Fuster, C Garcia-de-la-Maria, M Hernandez-Meneses, J Llopis, F Marco, I Ruiz-Zamora, A Bardaji Ruiz, E Sanz Girgas, G Garcia-Pardo, M Guillen Marzo, A Rodriguez Oviedo, A Villares Jimenez, L Abid, R Hammami, S Kammoun, M S Mourali, F Mghaieth Zghal, M Ben Hlima, S Boudiche, S Ouali, L Zakhama, S Antit, I Slama, O Gulel, M Sahin, E Karacaglar, S Kucukoglu, O Cetinarslan, U Y Sinan, U Canpolat, B Mutlu, H Atas, R Dervishova, C Ileri, J Alhashmi, J Tahir, P Zarger, F Baslib, S Woldman, L Menezes, C Primus, R Uppal, I Bvekerwa, B Chandrasekaran, A Kopanska, J Chambers, J Hancock, J Klein, R Rajani, M P Ursi, S Cannata, R Dworakowski, A Fife, J Breeze, M Browne-Morgan, M Gunning, S Streather, F M Asch, M Zemedkun, B Alyavi, J Uzokov, G., Habib, P. A., Erba, B., Iung, E., Donal, B., Cosyn, C., Laroche, B. A., Popescu, B., Prendergast, P., Torno, A., Sadeghpour, L., Oliver, J. -J., Vaskelyte, R., Sow, O., Axler, A. P., Maggioni, P, Lancellotti, P Gale, C, Beleslin, B, Budaj, A, Chioncel, O, Dagres, N, Danchin, N, Emberson, J, Erlinge, D, Glikson, M, Gray, A, Kayikcioglu, M, P Maggioni, A, K Nagy, V, Nedoshivin, A, Petronio, A-S, Roos-Hesselink, J, Wallentin, L, Zeymer, U, Habib, G, Lancellotti, P, Cosyns, B, Donal, E, Erba, P, Iung, B, A Popescu, B, Prendergast, B, Tornos, P, Andarala, M, Berle, C, Brunel-Lebecq, A, Fiorucci, E, Laroche, C, Missiamenou, V, Taylor, C, N Ali Tatar-Chentir, N, Al-Mallah, M, Astrom Aneq, M, Athanassopoulos, G, P Badano, L, Benyoussef, S, Calderon Aranda, E, M Cardim, N, Chan, K-L, Cruz, I, Edvardsen, T, Goliasch, G, Hagendorff, A, Hristova, K, Kamp, O, Kang, D-H, Kong, W, Matskeplishvili, S, Meshaal, M, Mirocevic, M, N Neskovic, A, Pazdernik, M, Plonska-Gosciniak, E, Raissouni, M, Ronderos, R, E Sade, L, Sadeghpour, A, Sambola, A, Sengupta, S, Separovic-Hanzevacki, J, Takeuchi, M, Tucay, E, C Tude Rodrigues, A, Varga, A, Vaskelyte, J, Yamagata, K, Yiangou, K, Zaky, H, Granada, I, Mahia, M, Ressi, S, Nacinovich, F, Iribarren, A, Fernandez Oses, P, Avegliano, G, Filipini, E, Obregon, R, Bangher, M, Dho, J, Cartasegna, L, L Plastino, M, Novas, V, Shigel, C, Reyes, G, De Santos, M, Gastaldello, N, Granillo Fernandez, M, Potito, M, Streitenberger, G, Velazco, P, H Casabé, J, Cortes, C, Guevara, E, Salmo, F, Seijo, M, Weidinger, F, Heger, M, Brooks, R, Stöllberger, C, Ho, C-Y, Perschy, L, Puskas, L, Binder, C, Rosenhek, R, Schneider, M, Winter, M-P, Hoffer, E, Melissopoulou, M, Lecoq, E, Legrand, D, Jacquet, S, Massoz, M, Pierard, L, Marchetta, S, Dulgheru, R, D Emal, C, Oury, C, Droogmans, S, Kerkhove, D, Plein, D, Soens, L, Weytjens, C, Motoc, A, Roosens, B, Lemoine, I, Rodrigus, I, Paelinck, B, Amsel, B, Unger, P, Konopnicki, D, Beauloye, C, Pasquet, A, L Vanoverschelde, J, Pierard, S, Vancraeynest, D, Sinnaeve, F, L Andrade, J, Staszko, K, Dos Santos Monteiro, R, H Miglioranza, M, L Shuha, D, Alcantara, M, Cravo, V, Fazzio, L, Felix, A, Iso, M, Musa, C, P Siciliano, A, Villaca Filho, F, Rodrigues, A, Vilela, F, Braga, J, Silva, R, Rodrigues, D, Silva, L, Morhy, S, Fischer, C, Vieira, M, Afonso, T, Abreu, J, N Falcao, S, A Moises, V, Gouvea, A, J Mancuso, F, C Souza, A, Y Silva, C, João, G, S Abboud, C, Bellio de Mattos Barretto, R, Ramos, A, Arnoni, R, E Assef, J, J Della Togna, D, Le Bihan, D, Miglioli, L, P Romero Oliveira, A, Tadeu Magro Kroll, R, Cortez, D, L Gelape, C, C Peirira Nunes, M D, C De Abreu Ferrari, T, Hay, K, Le, V, Page, M, Poulin, F, Sauve, C, Serri, K, Mercure, C, Beaudoin, J, Pibarot, P, A Sebag, I, G Rudski, L, Ricafort, G, Barsic, B, Krajinovic, V, Vargovic, M, Lovric, D, Reskovic-Luksic, V, Vincelj, J, Jaksic Jurinjak, S, Yiannikourides, V, Ioannides, M, Pofaides, C, Masoura, V, Pudich, J, Linhart, A, Siranec, M, Marek, J, Blechova, K, Kamenik, M, Pelouch, R, Coufal, Z, Mikulica, M, Griva, M, Jancova, E, Mikulcova, M, Taborsky, M, Precek, J, Jecmenova, M, Latal, J, Widimsky, J, Butta, T, Machacek, S, Vancata, R, Spinar, J, Holicka, M, Pow Chon Long, F, Anzules, N, Bajana Carpio, A, Largacha, G, Penaherrera, E, Moreira, D, Mahfouz, E, Elsafty, E, Soliman, A, Zayed, Y, Aboulenein, J, Abdel-Hay, M, Almaghraby, A, Abdelnaby, M, Ahmed, M, Hammad, B, Saleh, Y, Zahran, H, Elgebaly, O, Saad, A, Ali, M, Zeid, A, El Sharkawy, R, Al Kholy, A, Doss, R, Osama, D, Rizk, H, Elmogy, A, Mishriky, M, Assayag, P, El Hatimi, S, Hubert, S, Casalta, J-P, Gouriet, F, Arregle, F, Cammilleri, S, Tessonnier, L, Riberi, A, Botelho-Nevers, E, Gagneux-Brunon, A, Pierrard, R, Tulane, C, Campisi, S, Fuzellier, J-F, Detoc, M, Mehalla, T, Boutoille, D, S Lecompte, A, Lefebvre, M, Pattier, S, Al Habash, O, Asseray-Madani, N, Biron, C, Brochard, J, Caillon, J, Cueff, C, Le Tourneau, T, Lecomte, R, M Magali Michel, M, Orain, J, Delarue, S, Le Bras, M, Faucher, J-F, Aboyans, V, Beeharry, A, Durox, H, Lacoste, M, Magne, J, Mohty, D, David, A, Pradel, V, Sierra, V, Neykova, A, Bettayeb, B, Elkentaoui, S, Tzvetkov, B, Landry, G, Strady, C, Ainine, K, Baumard, S, Brasselet, C, Tassigny, C, Valente-Pires, V, Lefranc, M, Hoen, B, Lefevre, B, Curlier, E, Callier, C, Fourcade, N, Jobic, Y, Ansard, S, Le Berre, R, Le Ven, F, Pouliquen, M-C, Prat, G, Le Roux, P, Bouchart, F, Savoure, A, Alarcon, C, Chapuzet, C, Gueit, I, Tribouilloy, C, Bohbot, Y, Peugnet, F, Gun, M, Duval, X, Lescure, X, Ilic-Habensus, E, Sadoul, N, Selton-Suty, C, Alla, F, Goehringer, F, Huttin, O, Chevalier, E, Garcia, R, Le Marcis, V, Tattevin, P, Flecher, E, Revest, M, Chirouze, C, Bouiller, K, Hustache-Mathieu, L, Klopfenstein, T, Moreau, J, Fournier, D, Brunel, A-S, Lim, P, Oliver, L, Ternacle, J, Moussafeur, A, Chavanet, P, Piroth, L, Salmon-Rousseau, A, Buisson, M, Mahy, S, Martins, C, Gohier, S, Axler, O, Baumann, F, Lebras, S, Piper, C, Guckel, D, Börgermann, J, Horstkotte, D, Winkelmann, E, Brockmeier, B, Grey, D, Nickenig, G, Schueler, R, Öztürk, C, Stöhr, E, Hamm, C, Walther, T, Brandt, R, Frühauf, A-C, T Hartung, C, Hellner, C, Wild, C, Becker, M, Hamada, S, Kaestner, W, Stangl, K, Knebel, F, Baldenhofer, G, Brecht, A, Dreger, H, Isner, C, Pfafflin, F, Stegemann, M, Zahn, R, Fraiture, B, Kilkowski, C, Karcher, A-K, Klinger, S, Tolksdorf, H, Tousoulis, D, Aggeli, C, Sideris, S, Venieri, E, Sarri, G, Tsiapras, D, Armenis, I, Koutsiari, A, Floros, G, Grassos, C, Dragasis, S, Rallidis, L, Varlamos, C, Michalis, L, Naka, K, Bechlioulis, A, Kotsia, A, Lakkas, L, Pappas, K, Papadopoulos, C, Kiokas, S, Lioni, A, Misailidou, S, Barbetseas, J, Bonou, M, Kapelios, C, Tomprou, I, Zerva, K, Manolis, A, Hamodraka, E, Athanasiou, D, Haralambidis, G, Samaras, H, Poulimenos, L, Nagy, A, Bartykowszki, A, Gara, E, Mungulmare, K, Kasliwal, R, Bansal, M, Ranjan, S, Bhan, A, Kyavar, M, Maleki, M, Noohi Bezanjani, F, Alizadehasl, A, Boudagh, S, Ghavidel, A, Moradnejad, P, R Pasha, H, Ghadrdoost, B, Gilon, D, Strahilevitz, J, Wanounou, M, Israel, S, D'Agostino, C, Colonna, P, De Michele, L, Fumarola, F, Stante, M, Marchionni, N, Scheggi, V, Alterini, B, Del Pace, S, Stefano, P, Sparano, C, Ruozi, N, Tenaglia, R, Muraru, D, Limbruno, U, Cresti, A, Baratta, P, Solari, M, Giannattasio, C, Moreo, A, De Chiara, B, Lopez Montero, B, Musca, F, A Orcese, C, Panzeri, F, Spano, F, F Russo, C, Alfieri, O, DE BONIS, Michele, Chiappetta, S, Del Forno, B, Ripa, M, Scarpellini, P, Tassan Din, C, Castiglioni, B, Pasciuta, R, Carletti, S, Ferrara, D, Guffanti, M, Iaci, G, Lapenna, E, Nisi, T, Oltolini, C, Busnardo, E, Pajoro, U, Agricola, E, Meneghin, R, Schiavi, D, Piscione, F, Citro, R, M Benvenga, R, Greco, L, Soriente, L, Radano, I, Prota, C, Bellino, M, Di Vece, D, Santini, F, Salsano, A, M Olivieri, G, Turrini, F, Messora, R, Tondi, S, Olaru, A, Agnoletto, V, Grassi, L, Leonardi, C, Sansoni, S, Del Ponte, S, M Actis Dato, G, De Martino, A, Ohte, N, Kikuchi, S, Wakami, K, Aonuma, K, Seo, Y, Ishizu, T, Machino-Ohtsuka, T, Yamamoto, M, Iida, N, Nakajima, H, Nakagawa, Y, Izumi, C, Amano, M, Miyake, M, Takahashi, K, Shiojima, I, Miyasaka, Y, Maeba, H, Suwa, Y, Taniguchi, N, Tsujimoto, S, Kitai, T, Ota, M, Yuda, S, Sasaki, S, Hagiwara, N, Yamazaki, K, Ashihara, K, Arai, K, Saitou, C, Saitou, S, Suzuki, G, Shibata, Y, Watanabe, N, Nishino, S, Ashikaga, K, Kuriyama, N, Mahara, K, Okubo, T, Fujimaki, H, Shitan, H, Yamamoto, H, Abe, K, Terada, M, Takanashi, S, Sata, M, Yamada, H, Kusunose, K, Saijo, Y, Seno, H, Yuichiro, O, Onishi, T, Sera, F, Nakatani, S, Mizuno, H, Sengoku, K, W Park, S, Eun Kyoung, K, Ga Yeon, L, Hwang, J-W, Jin-Oh, C, Park, S-J, Sang-Chol, L, Sung-A, C, Y Jang, S, Heo, R, Lee, S, Song, J-M, Jung, E, Plisiene, J, Dambrauskaite, A, Gruodyte, G, Jonkaitiene, R, Mizariene, V, Atkocaityte, J, Zvirblyte, R, Sow, R, Codreanu, A, Staub, T, Michaux, C, L De la Vega, E C, Jacobs-Orazi, L, Mallia Azzopardi, C, G Xuereb, R, Piscopo, T, Farrugia, J, Fenech, M, Pllaha, E, Vella, C, Borg, D, Casha, R, Grib, L, Raevschi, E, Grejdieru, A, Kravcenco, D, Prisacari, E, Samohvalov, E, Samohvalov, S, Sceglova, N, Panfile, E, Cardaniuc, L, Corcea, V, Feodorovici, A, Gaina, V, Girbu, L, Jimbei, P, Balan, G, Cardaniuc, I, Benesco, I, Marian, V, Sumarga, N, Bozovic, B, Bulatovic, N, Lakovic, P, Music, L, Budde, R, Wahadat, A, Gamela, T, Meijers, T, P Van Melle, J, M Deursen, V, J Crijns, H, C Bekkers, S, C Cheriex, E, Gilbers, M, L Kietselaer, B, Knackstedt, C, Lorusso, R, Schalla, S, A Streukens, S, Chamuleau, S, Cramer, M-J, Teske, A, Van der Spoel, T, Wind, A, Lokhorst, J, Liesbek, O, Van Heusden, H, Tanis, W, Van der Bilt, I, Vriend, J, De Lange-van Bruggen, H, Karijodikoro, E, Riezebos, R, van Dongen, E, Schoep, J, Stolk, V, T Offstad, J, O Beitnes, J, Helle-Valle, T, Skulstad, H, Skardal, R, Qamar, N, Furnaz, S, Ahmed, B, H Butt, M, F Khanzada, M, Saghir, T, Wahid, A, Hryniewiecki, T, Szymanski, P, Marzec, K, Misztal-Ogonowska, M, Kosmala, W, Przewlocka-Kosmala, M, Rojek, A, Woznicka, K, Zachwyc, J, Lisowska, A, Kaminska, M, D Kasprzak, J, Kowalczyk, E, F Strzecka, D, Wejner-Mik, P, Trabulo, M, Freitas, P, Ranchordas, S, Rodrigues, G, Pinto, P, Queiros, C, Azevedo, J, Marques, L, Seabra, D, Branco, L, Cruz, M, Galrinho, A, Moreira, R, Rio, P, T Timoteo, A, Selas, M, Carmelo, V, Duque Neves, B, Pereira, H, Guerra, A, Marques, A, Pintassilgo, I, C Tomescu, M, Trofenciuc, N-M, Andor, M, Bordejevic, A, S Branea, H, Caruntu, F, A Velcean, L, Mavrea, A, F Onel, M, Parvanescu, T, Pop, D, L Pop-Moldovan, A, I Puticiu, M, Cirin, L, M Citu, I, A Cotoraci, C, Darabantiu, D, Farcas, R, Marincu, I, Ionac, A, Cozma, D, Mornos, C, Goanta, F, Popescu, I, Beyer, R, Mada, R, Rancea, R, Tomoaia, R, Rosianu, H, Stanescu, C, Kobalava, Z, Karaulova, J, Kotova, E, Milto, A, Pisaryuk, A, Povalyaev, N, Sorokina, M, Alrahimi, J, Elshiekh, A, Jamiel, A, Ahmed, A, Attia, N, Putnikovic, B, Dimic, A, Ivanovic, B, Matic, S, Trifunovic, D, Petrovic, J, Kosevic, D, Stojanovic, I, Petrovic, I, Dabic, P, Milojevic, P, Srdanovic, I, Susak, S, Velicki, L, Vulin, A, Kovacevic, M, Redzek, A, Stefanovic, M, C Yeo, T, Kf Kong, W, K Poh, K, Vilacosta, I, Ferrera, C, Olmos, C, Abd El-Nasser, M, Calvo Iglesias, F, Blanco-Gonzalez, E, Bravo Amaro, M, Lopez-Rodriguez, E, Lugo Adan, J, N Germinas, A, Pazos-Lopez, P, Pereira Loureiro, M, T Perez, M, Raposeiras-Roubin, S, Rasheed Yas, S, Suarez-Varela, M-M, Vasallo Vidal, F, Garcia-Dorado, D, Fernandez-Hidalgo, N, Gonzalez-Alujas, T, Lozano, J, Maisterra, O, Pizzi, N, Rios, R, Bayes-Genis, A, Pedro Botet, L, Vallejo, N, Llibre, C, Mateu, L, Nunez, R, Quesada, D, Berastegui, E, Bosch Portell, D, Aboal Vinas, J, Albert Bertran, X, Brugada Tarradellas, R, Loma-Osorio Ricon, P, Tiron de Llano, C, A Arnau, M, Bel, A, Blanes, M, Osa, A, Anguita, M, Carrasco, F, C Castillo, J, L Zamorano, J, L Moya Mur, J, Alvaro, M, Fernandez-Golfin, C, M Monteagudo, J, Navas Elorza, E, C Farinas Alvarez, M, Aguero Balbin, J, Zarauza, J, F Gutierrez-Diez, J, Arminanzas, C, Arnaiz de Las Revillas, F, Arnaiz Garcia, A, Cobo Belaustegui, M, Fernandez Sampedro, M, Gutierrez Cuadra, M, Garcia Cuello, L, Gonzalez Rico, C, Rodriguez-Alvarez, R, Goikoetxea, J, Montejo, M, M Miro, J, Almela, M, Ambrosioni, J, Moreno, A, Quintana, E, Sandoval, E, Tellez, A, M Tolosana, J, Vidal, B, Falces, C, Fuster, D, Garcia-de-la-Maria, C, Hernandez-Meneses, M, Llopis, J, Marco, F, Ruiz-Zamora, I, Bardaji Ruiz, A, Sanz Girgas, E, Garcia-Pardo, G, Guillen Marzo, M, Rodriguez Oviedo, A, Villares Jimenez, A, Abid, L, Hammami, R, Kammoun, S, S Mourali, M, Mghaieth Zghal, F, Ben Hlima, M, Boudiche, S, Ouali, S, Zakhama, L, Antit, S, Slama, I, Gulel, O, Sahin, M, Karacaglar, E, Kucukoglu, S, Cetinarslan, O, Y Sinan, U, Canpolat, U, Mutlu, B, Atas, H, Dervishova, R, Ileri, C, Alhashmi, J, Tahir, J, Zarger, P, Baslib, F, Woldman, S, Menezes, L, Primus, C, Uppal, R, Bvekerwa, I, Chandrasekaran, B, Kopanska, A, Chambers, J, Hancock, J, Klein, J, Rajani, R, P Ursi, M, Cannata, S, Dworakowski, R, Fife, A, Breeze, J, Browne-Morgan, M, Gunning, M, Streather, S, M Asch, F, Zemedkun, M, Alyavi, B, Uzokov, J, Hôpital de la Timone [CHU - APHM] (TIMONE), Microbes évolution phylogénie et infections (MEPHI), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), University Medical Center Groningen [Groningen] (UMCG), Laboratoire Traitement du Signal et de l'Image (LTSI), Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Pontchaillou [Rennes], Université de Médecine Carol Davila, Guy's and St Thomas' Hospital [London], CHU Henri Mondor, Centre Hospitalier Universitaire de Liège (CHU-Liège), AstraZeneca, Bayer, Edwards Lifesciences, Servier, Abbott Vascular Int., Amgen Cardiovascular, Pfizer Alliance, Daiichi Sankyo Europe GmbH, Alliance Daiichi Sankyo Europe GmbH, Gedeon Richter Plc., Menarini Int. Op., Vifor, Boehringer Ingelheim, Boston Scientific Corporation, Bristol-Myers Squibb, Eli Lilly and Company, UCL - SSS/IREC/CARD - Pôle de recherche cardiovasculaire, UCL - (SLuc) Service de pathologie cardiovasculaire, UCL - (SLuc) Service de pathologies cardiovasculaires intensives, UCL - (SLuc) Service de soins intensifs, Service de cardiologie, Université de la Méditerranée - Aix-Marseille 2-Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE), Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU), CIC - CHU Bichat, Institut National de la Santé et de la Recherche Médicale (INSERM), Service de cardiologie et maladies vasculaires, Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Hôpital Pontchaillou-CHU Pontchaillou [Rennes], Oxford University Hospitals NHS Trust, University of Oxford [Oxford], Université Paris-Est Créteil Val-de-Marne - Faculté de médecine (UPEC Médecine), Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Université de Bordeaux (UB), Research Center [Associazione Nazionale Medici Cardiologi Ospedalieri] (ANMCO Research Center), Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO), Service de cardiologie [Liège], CHU de Liège-Domaine Universitaire du Sart Tilman, Paris-Centre de Recherche Cardiovasculaire (PARCC - UMR-S U970), Université Paris Descartes - Paris 5 (UPD5)-Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Institut National de la Santé et de la Recherche Médicale (INSERM), University of Exeter, Instituto Nacional de Tecnología Agropecuaria, Pergamino, Argentina, Laboratory of In Vivo Cellular and Molecular Imaging, Vrije Universiteit Brussel (VUB), Centre National de la Recherche Scientifique (CNRS), Division of Engineering and Applied Science, California Institute of Technology, California Institute of Technology (CALTECH), Departamento de Biologia de la Reproduccion, Universidad Autónoma Metropolitana Iztapalapa (UAMI), Universidade Federal de Itajubá, Departamento de Física [Coimbra] (DFC), Universidade de Coimbra [Coimbra], Section of Internal Medicine and Endocrine and Metabolic Sciences, Università degli Studi di Perugia (UNIPG), LIP-Coimbra & Department of Physics of the University of Coimbra, Service Hospitalier Frédéric Joliot (SHFJ), Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay, Quebec Heart Institute/Laval Hospital, Université Laval [Québec] (ULaval)-Quebec Heart Institute, Institut Lavoisier de Versailles (ILV), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Centre National de la Recherche Scientifique (CNRS), Institut Hospitalier Universitaire Méditerranée Infection (IHU AMU), CHU Saint-Etienne, Centre Hospitalier Universitaire de Saint-Etienne (CHU de Saint-Etienne), Service des maladies infectieuses et tropicales [CHU Nantes], Centre hospitalier universitaire de Nantes (CHU Nantes), Service de bactériologie et hygiène hospitalière [Nantes], Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes), Institut du thorax, Université de Nantes (UN)-IFR26-Institut National de la Santé et de la Recherche Médicale (INSERM), Service des Maladies infectieuses et tropicales [CHU Limoges], CHU Limoges, Hôpital Sainte-Marguerite [CHU - APHM] (Hôpitaux Sud ), Centre Hospitalier Universitaire de Reims (CHU Reims), Anesthésie et réanimation en chirurgie cardiaque [CHU Rouen], CHU Rouen, Normandie Université (NU)-Normandie Université (NU), Normandie Université (NU), Service des maladies infectieuses et tropicales [Rouen], Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Mécanismes physiologiques et conséquences des calcifications cardiovasculaires: rôle des remodelages cardiovasculaires et osseux, Université de Picardie Jules Verne (UPJV)-Institut National de la Santé et de la Recherche Médicale (INSERM), Department of Cardiology [Ospedali del Tigullio], Modèles et méthodes de l'évaluation thérapeutique des maladies chroniques (U738 / UMR_S738), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Diderot - Paris 7 (UPD7), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], Maladies chroniques, santé perçue, et processus d'adaptation (APEMAC), Université de Lorraine (UL), Service des Maladies Infectieuses et Tropicales [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Service de Cardiologie [CHRU Nancy], Service des maladies infectieuses et réanimation médicale, Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Hôpital Pontchaillou, Service de chirurgie thoracique cardiaque et vasculaire [Rennes], Laboratoire Chrono-environnement - CNRS - UFC (UMR 6249) (LCE), Centre National de la Recherche Scientifique (CNRS)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), service de maladies infectieuses CHU J Minjoz Besancon, Hôpital Jean Minjoz, Centre Hospitalier Régional Universitaire [Besançon] (CHRU Besançon), Département d'infectiologie (CHU de Dijon), Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Virologie et pathogenèse virale (VPV), Centre National de la Recherche Scientifique (CNRS)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon, Institució Catalana de Recerca i Estudis Avançats (ICREA), Institute for Advanced Studies in Basic Sciences, affiliation inconnue, Dipartamento di Fisica 'E.R. Caianiello', Università degli Studi di Salerno (UNISA), The University of Tokyo, Northern Research Station, Forestry Commission, University of North Carolina [Chapel Hill] (UNC), University of North Carolina System (UNC), Instituto de Plasmas e Fusão Nuclear [Lisboa] (IPFN), Instituto Superior Técnico, Universidade Técnica de Lisboa (IST), Instituto de Investigaciones Marinas (CSIC), Faculté des Sciences Pharmaceutiques, EA 4529, Laboratoire de Biochimie, Université Paris-Sud - Paris 11 (UP11), Istituto di Virologia Vegetale, Università degli studi di Torino (UNITO), Universidad Nacional Autónoma de México (UNAM), Service de Chirurgie Cardiovasculaire, University Hospital of Cruces, Geneva University Hospital (HUG), Institut Jean Le Rond d'Alembert (DALEMBERT), Université Pierre et Marie Curie - Paris 6 (UPMC)-Centre National de la Recherche Scientifique (CNRS), Preventive Medicine Unit, University Hospital Joan XXIII, IISPV, Rovira and Virgili University, Popescu, B, Maggioni, A, Gale, C, Nagy, V, Petronio, A, Ali Tatar-Chentir, N, Badano, L, Cardim, N, Chan, K, Kang, D, Neskovic, A, Sade, L, Tude Rodrigues, A, Plastino, M, Casabe, J, Stollberger, C, Ho, C, Winter, M, Emal, C, Vanoverschelde, J, Andrade, J, Miglioranza, M, Shuha, D, Siciliano, A, Falcao, S, Moises, V, Mancuso, F, Souza, A, Silva, C, Joao, G, Abboud, C, Assef, J, Della Togna, D, Romero Oliveira, A, Gelape, C, Peirira Nunes, M, De Abreu Ferrari, T, Sebag, I, Rudski, L, Casalta, J, Fuzellier, J, Lecompte, A, Magali Michel, M, Faucher, J, Pouliquen, M, Brunel, A, Borgermann, J, Ozturk, C, Stohr, E, Fruhauf, A, Hartung, C, Karcher, A, Pasha, H, Orcese, C, Russo, C, De Bonis, M, Benvenga, R, Olivieri, G, Actis Dato, G, Park, S, Hwang, J, Jang, S, Song, J, De la Vega, E, Xuereb, R, Van Melle, J, Deursen, V, Crijns, H, Bekkers, S, Cheriex, E, Kietselaer, B, Streukens, S, Cramer, M, Offstad, J, Beitnes, J, Butt, M, Khanzada, M, Kasprzak, J, Strzecka, D, Timoteo, A, Tomescu, M, Trofenciuc, N, Branea, H, Velcean, L, Onel, M, Pop-Moldovan, A, Puticiu, M, Citu, I, Cotoraci, C, Yeo, T, Poh, K, Germinas, A, Perez, M, Suarez-Varela, M, Arnau, M, Castillo, J, Zamorano, J, Moya Mur, J, Monteagudo, J, Farinas Alvarez, M, Gutierrez-Diez, J, Miro, J, Tolosana, J, Mourali, M, Yasar, U, Ursi, M, Asch, F, Clinical sciences, Cardio-vascular diseases, Cardiology, Medical Imaging, Cardiovascular Centre (CVC), Service de médecine nucléaire [Marseille], Imagerie MOléculaire pour applications THéranostiques personnalisées (IMOTHEP), Institut FRESNEL (FRESNEL), Aix Marseille Université (AMU)-École Centrale de Marseille (ECM)-Centre National de la Recherche Scientifique (CNRS)-Aix Marseille Université (AMU)-École Centrale de Marseille (ECM)-Centre National de la Recherche Scientifique (CNRS)- Hôpital de la Timone [CHU - APHM] (TIMONE), Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Paris-Saclay-Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS), Centre National de la Recherche Scientifique (CNRS)-Université Pierre et Marie Curie - Paris 6 (UPMC), MGSOG Scientific staff, MUMC+: MA Cardiologie (9), Cardiologie, RS: Carim - H01 Clinical atrial fibrillation, RS: CARIM - R2.01 - Clinical atrial fibrillation, RS: CARIM - R3.11 - Imaging, Promovendi CD, Fysiologie, MUMC+: MA Med Staf Artsass CTC (9), RS: CARIM - R1.06 - Genetic Epidemiology and Genomics of cardiovascular diseases, MUMC+: MA Med Staf Spec Cardiologie (9), RS: Carim - H02 Cardiomyopathy, RS: CARIM - R2.02 - Cardiomyopathy, CTC, MUMC+: MA Med Staf Spec CTC (9), RS: Carim - V04 Surgical intervention, RS: CARIM - R2.12 - Surgical intervention, RS: FdR IC Aansprakelijkheid, Graduate School, ACS - Heart failure & arrhythmias, Radiotherapy, CCA - Imaging and biomarkers, CCA - Cancer Treatment and Quality of Life, and ACS - Atherosclerosis & ischemic syndromes
Subjects: Male, SURGERY, Embolism, Infective endocarditi, Infective endocarditis, Registry, Valve disease, 030204 cardiovascular system & hematology, 0302 clinical medicine, Africa, Northern, Positron Emission Tomography Computed Tomography, 030212 general & internal medicine, Hospital Mortality, Prospective Studies, Registries, Prospective cohort study, Abscess, Aged, 80 and over, medicine.diagnostic_test, Middle Aged, Staphylococcal Infections, 3. Good health, Cardiac surgery, Community-Acquired Infections, Europe, Treatment Outcome, Positron emission tomography, Echocardiography, Heart Valve Prosthesis, [SDV.IB]Life Sciences [q-bio]/Bioengineering, Female, ECHOCARDIOGRAPHY, Cardiology and Cardiovascular Medicine, Adult, medicine.medical_specialty, Asia, Prosthesis-Related Infections, DIAGNOSIS, 03 medical and health sciences, Fluorodeoxyglucose F18, Internal medicine, Streptococcal Infections, medicine, MANAGEMENT, Journal Article, Humans, Aged, business.industry, EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY, Endocarditis, Bacterial, South America, medicine.disease, Heart failure, Etiology, Radiopharmaceuticals, business, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology, Enterococcus
Abstract: Aims The EURO-ENDO registry aimed to study the management and outcomes of patients with infective endocarditis (IE). Methods and results Prospective cohort of 3116 adult patients (2470 from Europe, 646 from non-ESC countries), admitted to 156 hospitals in 40 countries between January 2016 and March 2018 with a diagnosis of IE based on ESC 2015 diagnostic criteria. Clinical, biological, microbiological, and imaging [echocardiography, computed tomography (CT) scan, 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT)] data were collected. Infective endocarditis was native (NVE) in 1764 (56.6%) patients, prosthetic (PVIE) in 939 (30.1%), and device-related (CDRIE) in 308 (9.9%). Infective endocarditis was community-acquired in 2046 (65.66%) patients. Microorganisms involved were staphylococci in 1085 (44.1%) patients, oral streptococci in 304 (12.3%), enterococci in 390 (15.8%), and Streptococcus gallolyticus in 162 (6.6%). 18F-fluorodeoxyglucose positron emission tomography/computed tomography was performed in 518 (16.6%) patients and presented with cardiac uptake (major criterion) in 222 (42.9%) patients, with a better sensitivity in PVIE (66.8%) than in NVE (28.0%) and CDRIE (16.3%). Embolic events occurred in 20.6% of patients, and were significantly associated with tricuspid or pulmonary IE, presence of a vegetation and Staphylococcus aureus IE. According to ESC guidelines, cardiac surgery was indicated in 2160 (69.3%) patients, but finally performed in only 1596 (73.9%) of them. In-hospital death occurred in 532 (17.1%) patients and was more frequent in PVIE. Independent predictors of mortality were Charlson index, creatinine > 2 mg/dL, congestive heart failure, vegetation length > 10 mm, cerebral complications, abscess, and failure to undertake surgery when indicated. Conclusion Infective endocarditis is still a life-threatening disease with frequent lethal outcome despite profound changes in its clinical, microbiological, imaging, and therapeutic profiles.
Published: 2019

16. Actualización del documento de consenso sobre el diagnóstico y tratamiento de la faringoamigdalitis aguda

Author: Roi Piñeiro Pérez, Fernando Álvez González, Fernando Baquero-Artigao, Marta Cruz Cañete, Josep de la Flor i Bru, Ana Fernández Landaluce, César García Vera, Francisco Hijano Bandera, Carlos Pérez Cánovas, Juan Carlos Silva Rico, Santiago Alfayate Miguélez, Josefa Ares Álvarez, Alicia Berghezan Suárez, Ana María Borrull Senra, Gonzalo Cabrera Roca, Cristina Calvo Rey, Begoña Carazo Gallego, María José Cilleruelo Ortega, Antonio Conejo Fernández, Javier López Ávila, Pilar Lupiani Castellanos, Leticia Martínez Campos, and Jorge Sotoca Fernández
Subjects: 03 medical and health sciences, 0302 clinical medicine, Antibiotics, 030225 pediatrics, Pediatrics, Perinatology and Child Health, Diagnosis, Streptococcus, Appropriateness, Tonsillopharyngitis, Consensus document, Pediatrics, RJ1-570
Abstract: Resumen: Se presenta una actualización del documento de consenso sobre el diagnóstico y tratamiento de la faringoamigdalitis aguda, publicado en 2011. Las escalas de predicción clínica no deben ser utilizadas para iniciar antibioterapia, salvo que las pruebas microbiológicas no estén disponibles o exista riesgo de fiebre reumática. No existe ninguna escala que sea mejor que las expuestas en el consenso previo. Se proponen casos en los que se recomienda realizar pruebas microbiológicas, con independencia de los resultados de las escalas. El tratamiento de elección de la faringoamigdalitis estreptocócica es penicilina en dos dosis diarias y durante 10 días. Amoxicilina, en una o dos dosis diarias y durante el mismo tiempo, es la primera alternativa terapéutica. Las cefalosporinas de primera generación son el tratamiento de elección en niños con reacción retardada no grave a penicilina o amoxicilina. En reacciones alérgicas inmediatas deben utilizarse antibióticos no betalactámicos, siendo josamicina y diacetil-midecamicina las mejores opciones. En el fracaso terapéutico bacteriológico, y en el estado de portador, los tratamientos planteados en el consenso previo siguen siendo válidos. Abstract: An update of the Spanish consensus document on the diagnosis and treatment of acute tonsillopharyngitis is presented. Clinical scores should not be used to prescribe antibiotics, unless microbiological tests are not available or there is a child at risk of rheumatic fever. There is no score better than those set out in the previous consensus. Microbiological tests are recommended in proposed cases, regardless of the result of the scores. Penicillin is the treatment of choice, prescribed twice a day for 10 days. Amoxicillin is the first alternative, prescribed once or twice a day for the same time. First-generation cephalosporins are the treatment of choice in children with non-immediate reaction to penicillin or amoxicillin. Josamycin and midecamycin are the best options for children with immediate penicillin allergic reactions, when non-beta-lactam antibiotics should be used. In microbiological treatment failure, and in streptococcal carriers, the treatments proposed in the previous consensus are still applicable.
Published: 2020

17. Acid-base imbalance: a review with proposed unified diagnostic algorithm

Author: Ronald Castro Ahumada, Rodrigo Daza Arnedo, Nehomar Eduardo Pájaro Galvis, María Monterrosa Robles, Mauricio Batista Lambis, María Cardona Blanco, Isaias Garcerant Campo, Víctor Leal Martínez, Jorge Eduardo Rico Fontalvo, Jenniffer Palomino Herrera, Karen Perales Caballero, José Correa Guerrero, and Emilio Abuabara Franco
Subjects: algorithms (MeSH), diagnosis, business.industry, Process (engineering), Context (language use), General Medicine, desequilibrio ácido-base, Clinical correlation, medicine.disease, diagnóstico, algoritmos, Identification (information), Acid-base imbalance, blood gas analysis, análisis de los gases de la sangre, Medicine, business, Algorithm, Acid–base imbalance
Abstract: Introduction: Alterations in the acid-base balance are studied in all medical specialties. Although most cases derive from a preexisting pathology, they can also manifest themselves in a primary context. The proper identification of the acid-base disorder allows the pathological process to be characterized. The correct interpretation of the blood gasometry as a technique for monitoring the ventilatory status, oxygenation and acid-base balance of a patient requires the integration of various physicochemical approaches in order to specify a diagnosis, quantify a therapeutic response, and monitor the severity or the progression of a pathological process. Methodology: A literature review was conducted in the PubMed, Scopus and Science Direct databases. The articles were selected according to the title and the abstract and sorted by topics relevant by pathophysiology, divergences, clinical approach, diagnosis, and management. Results: A guide the clinical correlation of the critical patient with the blood gasometry parameters to characterize the acid-base disorder through the proposition of a diagnostic algorithm. Conclusion: The incorporation of the three theories in a diagnostic algorithm facilitates a greater understanding of the pathophysiological mechanisms and allows us to identify a more precise therapeutic objective to correct the underlying disorder in the different clinical contexts of the patient. Resumen Introducción: las alteraciones del equilibrio ácido-base se estudian en todas las especialidades médicas. Aunque la mayoría de los casos derivan de una patología preexistente, también pueden manifestarse en un contexto primario, por lo que la identificación adecuada del trastorno ácido-base permite caracterizar su proceso patológico. La correcta interpretación de la gasometría sanguínea como técnica para monitorizar el estado ventilatorio, la oxigenación y el equilibrio ácido-base de un paciente requiere la integración de varios enfoques fisicoquímicos para precisar un diagnóstico, cuantificar una respuesta terapéutica y monitorizar la gravedad o la progresión de un proceso patológico. Materiales y métodos: se realizó una revisión de la literatura en las bases de datos PubMed, Scopus y ScienceDirect. Los artículos fueron seleccionados según el título y el resumen, y ordenados por tópicos relevantes por fisiopatología, divergencias, abordaje clínico, diagnóstico y manejo. Resultados: en la literatura consultada se evidenció que el uso de un enfoque lógico y sistemático es necesario para interpretar adecuadamente los parámetros de la gasometría sanguínea e identificar oportunamente el trastorno ácido-base. Conclusión: la incorporación de las tres teorías en un algoritmo diagnóstico facilita una mayor comprensión de los mecanismos fisiopatológicos y permite identificar un objetivo terapéutico más preciso para corregir el trastorno de base en los diferentes contextos clínicos del paciente.
Published: 2020

18. Necrotizing cellulitis due to Rhizopus arrhizus in an extremely premature infant

Author: Álvaro Hoyos, Clara Rico, Andrés Soto, Verónica Herrera, and María Adelaida Mejía
Subjects: 0301 basic medicine, medicine.medical_specialty, 030106 microbiology, Infectious and parasitic diseases, RC109-216, Premature infant, Article, 03 medical and health sciences, 0302 clinical medicine, Diagnosis, Necrotizing cellulitis, Medicine, Mucormycosis, 030212 general & internal medicine, Rhizopus arrhizus, Extremely premature, biology, business.industry, medicine.disease, biology.organism_classification, Dermatology, Infectious Diseases, Minor trauma, Cellulitis, business
Abstract: We report an extremely premature infant with necrotizing cellulitis. After minor trauma to the left arm when removing an adhesive sensor, patient developed rapidly progressive cellulitis, which evolved into a necrotic ulcer. Microbiological studies (mass spectroscopy and molecular assay) identified Rhizopus arrhizus as the responsible fungus.
Published: 2020

19. Molecular Beacon for Detection miRNA-21 as a Biomarker of Lung Cancer.

Author: Alexandre, Daniela, Teixeira, Bernardo, Rico, André, Valente, Salete, Craveiro, Ana, Baptista, Pedro V., and Cruz, Carla
Subjects: BEACONS, LUNG cancer, MONONUCLEAR leukocytes, NON-small-cell lung carcinoma, BIOMARKERS, MEDICAL screening
Abstract: Lung cancer (LC) is the leading cause of cancer-related death worldwide. Although the diagnosis and treatment of non-small cell lung cancer (NSCLC), which accounts for approximately 80% of LC cases, have greatly improved in the past decade, there is still an urgent need to find more sensitive and specific screening methods. Recently, new molecular biomarkers are emerging as potential non-invasive diagnostic agents to screen NSCLC, including multiple microRNAs (miRNAs) that show an unusual expression profile. Moreover, peripheral blood mononuclear cells' (PBMCs) miRNA profile could be linked with NSCLC and used for diagnosis. We developed a molecular beacon (MB)-based miRNA detection strategy for NSCLC. Following PBMCs isolation and screening of the expression profile of a panel of miRNA by RT-qPCR, we designed a MB targeting of up-regulated miR-21-5p. This MB 21-5p was characterized by FRET-melting, CD, NMR and native PAGE, allowing the optimization of an in-situ approach involving miR-21-5p detection in PBMCs via MB. Data show the developed MB approach potential for miR-21-5p detection in PBMCs from clinical samples towards NSCLC. [ABSTRACT FROM AUTHOR]
Published: 2022
Full Text: View/download PDF

20. A study on the correlates of habit-, reward-, and fear-related motivations in alcohol use disorder

Author: Leonardo F. Fontenelle, Marcelo Piquet-Pessôa, Ana Paula Goulart Ribeiro, Gabriela M. Ferreira, Murat Yücel, Samuel R. Chamberlain, Gabriela Bezerra de Menezes, Marcelo Santos Cruz, Rico S.C. Lee, Lucy Albertella, Piquet-Pessôa, Marcelo [0000-0002-6981-8658], Chamberlain, Samuel R [0000-0001-7014-8121], and Apollo - University of Cambridge Repository
Subjects: Typology, Adult, Male, diagnosis, media_common.quotation_subject, Alcohol abuse, Alcohol, Alcohol use disorder, Models, Psychological, Article, 03 medical and health sciences, chemistry.chemical_compound, Habits, 0302 clinical medicine, Reward, medicine, substance abuse, Humans, Least-Squares Analysis, media_common, Addiction, Alcohol dependence, dependence, Fear, Middle Aged, medicine.disease, Classification, 030227 psychiatry, Substance abuse, Psychiatry and Mental health, Alcoholism, chemistry, Female, Neurology (clinical), Habit, Self Report, typology, Psychology, Goals, 030217 neurology & neurosurgery, Clinical psychology
Abstract: ObjectiveWe assessed self-reported drives for alcohol use and their impact on clinical features of alcohol use disorder (AUD) patients. Our prediction was that, in contrast to “affectively” (reward or fear) driven drinking, “habitual” drinking would be associated with worse clinical features in relation to alcohol use and higher occurrence of associated psychiatric symptoms.MethodsFifty-eight Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) alcohol abuse patients were assessed with a comprehensive battery of reward- and fear-based behavioral tendencies. An 18-item self-report instrument (the Habit, Reward and Fear Scale; HRFS) was employed to quantify affective (fear or reward) and non-affective (habitual) motivations for alcohol use. To characterize clinical and demographic measures associated with habit, reward, and fear, we conducted a partial least squares analysis.ResultsHabitual alcohol use was significantly associated with the severity of alcohol dependence reflected across a range of domains and with lower number of detoxifications across multiple settings. In contrast, reward-driven alcohol use was associated with a single domain of alcohol dependence, reward-related behavioral tendencies, and lower number of detoxifications.ConclusionThese results seem to be consistent with a shift from goal-directed to habit-driven alcohol use with severity and progression of addiction, complementing preclinical work and informing biological models of addiction. Both reward-related and habit-driven alcohol use were associated with lower number of detoxifications, perhaps stemming from more benign course for the reward-related and lack of treatment engagement for the habit-related alcohol abuse group. Future work should further explore the role of habit in this and other addictive disorders, and in obsessive-compulsive related disorders.
Published: 2019
Full Text: View/download PDF

21. Clinicopathological and Prognostic Significance of CD47 Expression in Lung Neuroendocrine Tumors.

Author: Orozco-Morales, Mario, Avilés-Salas, Alejandro, Hernández-Pedro, Norma, Catalán, Rodrigo, Cruz-Rico, Graciela, Colín-González, Ana Laura, Dosal-Mancilla, Elsa, Barrios-Bernal, Pedro, and Arrieta, Oscar
Subjects: NEUROENDOCRINE tumors, LUNG tumors, OVERALL survival, MELANOMA, HEMATOLOGIC malignancies, DIAGNOSIS
Abstract: Background: Lung neuroendocrine tumors account for approximately 15% of all lung cancer cases. LNET are subdivided into typical carcinoid (TC), atypical carcinoid (AC), large cell neuroendocrine carcinoma (LCNEC), and small-cell lung cancer (SCLC). The Ki-67 index has been used for decades to evaluate mitotic counts however, the role of Ki-67 as a biomarker for assessing prognosis and guiding therapy in metastatic LNET still lacks feasible clinical validation. Recent clinical trials have indicated that inhibition of CD47 with anti-CD47 antibodies exerts a promising antitumor effect against several human malignancies, including NSCLC, melanoma, and hematologic malignancies. However, the clinical relevance of CD47 expression in LNET has remained unclear.Methods: We performed a retrospective study in which we analyzed tumor biopsies from 51 patients with a confirmed diagnosis of LNET that received treatment at our hospital. Then, we analyzed if there was any correlation between CD47 expression with any clinical or pathological characteristic. We also analyzed the prognostic significance of CD47, assessed as progression-free survival and overall survival.Results: A total of 51 patients with LNET were enrolled in our study. The mean age at diagnosis was 57.6 (±11.6) years; 30 patients were women (59%). 27.5% of patients were positive for CD47 expression, and 72.5% of patients showed a CD47 expression of less than 1% and were considered as negatives. In patients with high-grade tumors (this time defined as Ki-67 > 40%), the positive expression of CD47 was strongly associated with an increased PFS. Albeit, these differences did not reach statistical significance when analyzing OS.Conclusion: Contrary to what happens in a wide range of hematologic and solid tumors, a higher expression of CD47 in patients with LNET is associated with a better progression-free survival, especially in patients with a Ki-67 ≥ 40%. This "paradox" remains to be confirmed and explained by larger studies. [ABSTRACT FROM AUTHOR]
Published: 2021
Full Text: View/download PDF

22. Oral decontamination with colistin plus neomycin in solid organ transplant recipients colonized by multidrug-resistant Enterobacterales: a multicentre, randomized, controlled, open-label, parallel-group clinical trial.

Author: Fariñas, Maria Carmen, González-Rico, Claudia, Fernández-Martínez, Marta, Fortún, Jesús, Escudero-Sanchez, Rosa, Moreno, Asunción, Bodro, Marta, Muñoz, Patricia, Valerio, Maricela, Montejo, Miguel, Nieto, Javier, Ruiz-San Millan, Juan Carlos, Casafont-Morencos, Fernando, Martinez-Martínez, Luis, and Fariñas-Álvarez, Concepción
Subjects: *COLISTIN, *NEOMYCIN, *TRANSPLANTATION of organs, tissues, etc., *CLINICAL trials, *DIAGNOSIS, *CARBAPENEMASE, *DENTAL facilities
Abstract: To evaluate the efficacy of oral colistin-neomycin in preventing multidrug-resistant Enterobacterales (MDR-E) infections in solid organ transplant (SOT) recipients. Multicentre, open-label, parallel-group, controlled trial with balanced (1:1) randomization in five transplant units. SOT recipients were screened for MDR-E intestinal colonization (extended-spectrum β-lactamase or carbapenemase producing) before transplantation and +7 and + 14 days after transplantation and assigned 1:1 to receive treatment with colistin sulfate plus neomycin sulfate for 14 days (decolonization treatment (DT) group) or no treatment (no decolonization treatment (NDT) group). The primary outcome was diagnosis of an MDR-E infection. Safety outcomes were appearance of adverse effects, mainly diarrhoea, rash, nausea and vomiting. Patients were monitored weekly until 30 days after treatment. Intention-to-treat analysis was performed. MDR-E rectal colonization was assessed in 768 SOT recipients; 105 colonized patients were included in the clinical trial, 53 receiving DT and 52 NDT. No significant decrease in the risk of infection by MDR-E was observed in the DT group (9.4%, 5/53) compared to the NDT group (13.5%, 7/52) (relative risk 0.70; 95% confidence interval 0.24–2.08; p 0.517). Four patients (5.6%), three (5.6%) in the DT group and one (1.9%) in the NDT group, developed colistin resistance. Twelve patients (22.7%) in the DT group had diarrhoea, eight related to treatment (15.0%); one patient (1.8%) developed skin rash and another (1.8%) nausea and vomiting. Two patients (3.8%) in the NDT group developed diarrhoea. DT does not reduce MDR-E infections in SOT. Colistin resistance and adverse effects such as diarrhoea are a potential issue that must be taken seriously. [ABSTRACT FROM AUTHOR]
Published: 2021
Full Text: View/download PDF

23. Quantification of Immune Dysregulation by Next-generation Polymerase Chain Reaction to Improve Sepsis Diagnosis in Surgical Patients.

Author: Almansa, Raquel, Ortega, Alicia, Ávila-Alonso, Ana, Heredia-Rodríguez, Maria, Martín, Silvia, Benavides, Diana, Martín-Fernandez, Marta, Rico, Lucia, Aldecoa, César, Rico, Jesús, López de Cenarruzabeitia, Iñigo, Beltrán de Heredia, Juan, Gomez-Sanchez, Esther, Aragón, Marta, Andrés, Cristina, Calvo, Dolores, Andaluz-Ojeda, David, Liu, Pilar, Blanco-Antona, Francisco, and Blanco, Lydia
Abstract: Supplemental Digital Content is available in the text Objectives: To quantify immunological dysfunction in surgical patients with presence/absence of sepsis using a droplet digital polymerase chain reaction (ddPCR) transcriptomic analysis. The study also aims to evaluate this approach for improving identification of sepsis in these patients. Background: Immune dysregulation is a central event in sepsis. Quantification of the expression of immunological genes participating in the pathogenesis of sepsis could represent a new avenue to improve its diagnosis. Methods: Expression of 6 neutrophil protease genes (MMP8 , OLFM4 , LCN2/NGAL , LTF , PRTN3 , MPO) and also of 5 genes involved in the immunological synapse (HLA-DRA , CD40LG , CD3E , CD28 , ICOS) was quantified in blood from 101 surgical patients with sepsis, 53 uninfected surgical patients, and 16 blood donors by using ddPCR. Areas under receiver operating characteristic curves (AUROC) and multivariate regression analysis were employed to test individual genes and gene ratios to identify sepsis, in comparison with procalcitonin. Results: Sepsis-induced overexpression of neutrophil protease genes and depressed expression of immunological synapse genes. MMP8/HLA-DRA , LCN2/HLA-DRA outperformed procalcitonin in differentiating between patients with sepsis and surgical controls in the AUROC analysis: LCN2/HLA-DRA : 0.90 (0.85–0.96), MMP8/HLA-DRA : 0.89 (0.84–0.95), procalcitonin: 0.80 (0.73–0.88) (AUROC, confidence interval 95%), and also in the multivariate analysis: LCN2/HLA-DRA : 8.57 (2.25–32.62); MMP8/HLA-DRA : 8.03 (2.10–30.76), procalcitonin: 4.20 (1.15–15.43) [odds ratio (confidence interval 95%)]. Gene expression levels of HLA-DRA were an independent marker of hospital mortality. Conclusions: Quantifying the transcriptomic ratios MMP8/HLA-DRA , LCN2/HLA-DRA by ddPCR is a promising approach to improve sepsis diagnosis in surgical patients. [ABSTRACT FROM AUTHOR]
Published: 2019
Full Text: View/download PDF

24. The interoperability between the Spanish version of the International Classification of Diseases and ORPHAcodes: towards better identification of rare diseases.

Author: Rico, Juan, Echevarría-González de Garibay, Luis Javier, García-López, María, Guardiola-Vilarroig, Sandra, Maceda-Roldán, Luis Alberto, Zurriaga, Óscar, and Cavero-Carbonell, Clara
Subjects: *NOSOLOGY, *RARE diseases, *DIAGNOSIS
Abstract: Background: Rare diseases present a wide spectrum of clinical manifestations and severity levels and are often poorly known and underrepresented, making them difficult to classify. Diagnoses are usually coded using the International Classification of Diseases (ICD), with its different versions. In Spain, the ICD-10-ES (stem from the ICD-10-CM-Clinical Modification) is used throughout the National Healthcare System since 2016, indistinctively including rare diseases that often lack a specific code. Orphanet aims to provide high-quality resources on rare diseases. The goal was to interrelate the Orphanet classification with the ICD-10-ES in order to engage a tool to track rare diseases diagnosis and characterize the improvement space for the identification of rare diseases patients in the Spanish Healthcare System.Methods: 5775 disorder level ORPHAcodes were mapped to ICD-10-ES codes by comparing the descriptors associated in both classifications. ORPHAcodes were then clustered based on their assigned ICD-10-ES chapter and the redundancy of each individual ICD-10-ES code was calculated by counting the ORPHAcodes they mapped to. Three groups were established: Group 1 (1 ORPHAcode per ICD-10-ES), Group 2 (between 2-49 ORPHAcodes per ICD-10-ES) and Group 3 (≥ 50 ORPHAcodes per ICD-10-ES).Results: Equivalences to 1700 ICD-10-ES codes were established for 5664 ORPHAcodes. The ORPHAcodes distribution within the ICD-10-ES showed an aggregation in the "Q" (> 40%), "G" (> 14%), and "E" (12%) chapters. The availability of ICD-10-ES codes to map ORPHAcodes reached its lowest at the "G" and "Q" chapters with less than 0.2 ICD-10-ES codes available per ORPHAcode. Global ICD-10-ES codes redundancy analysis revealed that only 1055 of the equivalences pertain to group 1. Group 2 contained 3358 equivalences with 634 ICD-10-ES codes while 1322 equivalences were group 3 (11 ICD-10-ES). Within ICD-10-ES chapters, "G" and "Q" contained over 30% and 45% of their own equivalences in the highest redundancy level (group 3) respectively, but under 10% one to one equivalences each (group 1).Conclusions: ICD-10-ES codes have not enough specificity to identify rare diseases. Direct mapping between ICD and ORPHAcodes or the integration of ORPHAcodes at the healthcare system for diagnoses codification would enable better detection and epidemiological analysis of rare diseases. [ABSTRACT FROM AUTHOR]
Published: 2021
Full Text: View/download PDF

25. Descubrimiento de conocimiento en incidencia de tipo de cáncer para pacientes terminales mediante minería de datos.

Author: Gutiérrez Pérez, Luis Antonio, Gutiérrez Cruz, Doricela, Rico Molina, Ricardo, Rodríguez Páez, Carmen Liliana, Albarrán Fernández, Yaroslaf Aarón, Soto Rivera, Bernardo, Gutiérrez Cruz, Alma Rebeca, and Duran López, Víctor Manuel
Subjects: DATA mining, GENDER, PALLIATIVE treatment, DIAGNOSIS, RECTUM
Abstract: Copyright of Ciencia Ergo Sum is the property of Universidad Autonoma del Estado de Mexico and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Published: 2021
Full Text: View/download PDF

26. Fatal underhanded chronic enterovirus infection associated with anti-CD20 monotherapy for central nervous system demyelinating disease.

Author: Luciani, Léa, Ninove, Laetitia, Zandotti, Christine, Chalvignac, Virginie, Lagier, David, Baume, Julien, Mélade, Julien, Piorkowski, Géraldine, Coutard, Bruno, Lepidi, Hubert, Pelletier, Jean, Audoin, Bertrand, Rico-Lamy, Audrey, and Nougairède, Antoine
Subjects: CENTRAL nervous system diseases, ENTEROVIRUS diseases, MYELIN sheath diseases, MYELIN oligodendrocyte glycoprotein, DIAGNOSIS
Abstract: We report a fatal case of coxsackievirus B4 chronic infection in a 30-year-old woman with a diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disorder controlled by rituximab monotherapy for 3 years. Initially presenting as self-limited meningitis, the infection remained silent for 8 months before the sudden onset of fulminant myocarditis. Analysis of the complete genome showed that the same virus was responsible for both episodes. [ABSTRACT FROM AUTHOR]
Published: 2021
Full Text: View/download PDF

27. Detecting SARS‐CoV‐2 RNA in conjunctival secretions: Is it a valuable diagnostic method of COVID‐19?

Author: Güemes‐Villahoz, Noemi, Burgos‐Blasco, Barbara, Arribi‐Vilela, Ana, Arriola‐Villalobos, Pedro, Rico‐Luna, Carla M., Cuiña‐Sardiña, Ricardo, Delgado‐Iribarren, Alberto, and García‐Feijoó, Julián
Subjects: COVID-19, SARS-CoV-2, ALLERGIC conjunctivitis, RNA
Abstract: The main purpose of this study is to evaluate the presence of viral RNA of severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) in conjunctival swab specimen of coronavirus disease 2019 (COVID‐19) patients with and without conjunctivitis to establish the diagnostic value of reverse transcription‐polymerase chain reaction (RT‐PCR) in each case and to describe its clinical characteristics. A cross‐sectional study was conducted at the Hospital Clinico San Carlos of Madrid, Spain. Thirty‐six subjects from the COVID admission unit with laboratory‐confirmed SARS‐CoV‐2 infection were included. Conjunctival swabs were collected from 18 patients with conjunctivitis and 18 patients without conjunctivitis and RT‐PCR was performed. Conjunctival swab was collected from both eyes of 36 patients (72 eyes), detecting SARS‐CoV‐2 RNA in conjunctival swab of two patients (5.5%). Among the 18 patients with conjunctivitis, only one of them (5.5%) showed positive results. Likewise, SARS‐CoV‐2 RNA was detected in one patient without conjunctivitis (5.5%). The mean age of the 36 patients was 67.9 years (range, 28‐92 years) and the male‐to‐female ratio was 0.44 (16:20). The mean days since the onset of COVID‐19 symptoms until conjunctivitis manifestation was 8 (range, 1‐24 days). The mean duration of the conjunctivitis was 3 days (range, 1‐7 days). SARS‐CoV‐2 RNA may be detected in conjunctival swabs of both patients with and without conjunctivitis. This study revealed the same rate of positive results amongst the group with and without conjunctivitis, suggesting that detecting SARS‐CoV‐2 in ocular fluids is not conditioned on the presence of conjunctivitis. The presence of SARS‐CoV‐2 RNA in ocular samples highlights the role of the eye as a possible route of transmission of the disease. Highlights: SARS‐CoV‐2 RNA can be detected in conjunctival secretions of both patients with and without conjunctivitis. However, PCR essay of tears and conjunctival secretions appear to have a fairly low potential of detecting the virus. [ABSTRACT FROM AUTHOR]
Published: 2021
Full Text: View/download PDF

28. Is a Diagnosis of Schizophrenia Spectrum Disorder Associated With Increased Mortality in Patients With COVID-19?

Author: Sánchez-Rico, Marina, Limosin, Frédéric, and Hoertel, Nicolas
Subjects: *SCHIZOPHRENIA, *COVID-19, *HEART failure, *DIAGNOSIS, *MENTAL health services
Abstract: In the article, the authors present their multicenter observational retrospective cohort study on the relationship between a schizophrenia spectrum disorder diagnosis and mortality in patients hospitalized for COVID-19. The aim is to determine the need for increased monitoring and targeted interventions of individuals with the said disorder against COVID-19. Also mentioned are the medical risk factors linked with severe COVID-19, including obesity, blood diseases and diabetes mellitus.
Published: 2022
Full Text: View/download PDF

29. Cancer characterization and diagnosis with SERS-encoded particles

Author: Ramon A. Alvarez-Puebla, Nicolas Pazos-Perez, Eduardo Garcia-Rico, and Luca Guerrini
Subjects: Materials science, Surface-enhanced Raman scattering, Biomedical Engineering, Pharmaceutical Science, Nanotechnology, 02 engineering and technology, 010402 general chemistry, lcsh:RC254-282, 01 natural sciences, Diagnosis, medicine, Physical and Theoretical Chemistry, Cancer, Prognosis, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, 021001 nanoscience & nanotechnology, medicine.disease, 0104 chemical sciences, Characterization (materials science), Oncology, Plasmonics, Nanomedicine, 0210 nano-technology, Plasmonic nanostructures, SERS-encoded particles
Abstract: Early diagnosis, monitoring and treatment selection of cancer represent major challenges in medicine. The definition of the complex clinical and molecular landscape of cancer requires the combination of multiple techniques and the investigation of multiple targets. As a result, diagnosis is normally lengthy, expensive and, in many cases, cannot be performed recursively. In recent years, optical biosensors, especially those based on the unique properties of plasmonic nanostructures, have emerged as one of the most exciting tools in nanomedicine, capable of overcoming key limitations of classical techniques. In this review, we specifically focus our attention on the latest advances in optical biosensors exploiting surface-enhanced Raman scattering encoded particles for the characterization of tumor single cells (molecular biology) and tissues (immunohistochemistry and guided surgery), as well as their application in guided surgery or even in bioimaging of living organisms.
Published: 2017
Full Text: View/download PDF

30. Surface-enhanced raman scattering surface selection rules for the proteomic liquid biopsy in real samples: Efficient detection of the oncoprotein c-MYC

Author: Arnau Torruella, Ramon A. Alvarez-Puebla, Nicolas Pazos-Perez, José L. Mascareñas, Manuel Garcia-Algar, Eduardo Garcia-Rico, M. Eugenio Vázquez, Moritz Nazarenus, Luca Guerrini, Cristina Penas, Elena Pazos, Universidade de Santiago de Compostela. Centro de Investigación en Química Biolóxica e Materiais Moleculares, Universidade de Santiago de Compostela. Departamento de Química Orgánica, Grupo de Plasmonica y Ultradetección, Química Física i Inorgànica, and Universitat Rovira i Virgili
Subjects: Raman scattering, Blood-based biomarkers, Biopsy, Analytical chemistry, 02 engineering and technology, 010402 general chemistry, 01 natural sciences, Biochemistry, Catalysis, symbols.namesake, Colloid and Surface Chemistry, Diagnosis, medicine, Liquid biopsy, Transcription factor, Chemistry, SERS, Espectroscòpia Raman amplificada en superfície, Cancer, Química, General Chemistry, Surface enhanced Raman Scattering, 021001 nanoscience & nanotechnology, medicine.disease, Plasmonic metamaterials, 0104 chemical sciences, 3. Good health, Investigación::23 Química [Materias], 0002-7863, Transducer, Sang -- Anàlisi, Biophysics, symbols, Biòpsia, 0210 nano-technology, Cancers
Abstract: NOTICE: This is the peer reviewed version of the following article: Elena Pazos, Manuel García-Algar, Cristina Penas, Moritz Nazarenus, Arnau Torruella, Nicolas Pazos-Perez, Luca Guerrini, M. Eugenio Vázquez, Eduardo Garcia-Rio*, José L. Macareñas* and Ramon A. Alvarez-Puebla* (2016), SERS Surface Selection Rules for the Proteomic Liquid Biopsy in Real Samples: Efficient Detection of the Oncoprotein cMYC. J. Am. Chem. Soc., 138, 14206-14209 [DOI: 10.1021/jacs.6b08957]. This article may be used for non-commercial purposes in accordance with ACS Publications Terms and Conditions for self-archiving Blood-based biomarkers (liquid biopsy) offer extremely valuable tools for the noninvasive diagnosis and monitoring of tumors. The protein c-MYC, a transcription factor that has been shown to be deregulated in up to 70% of human cancers, can be used as a robust proteomic signature for cancer. Herein, we developed a rapid, highly specific, and sensitive surface-enhanced Raman scattering (SERS) assay for the quantification of c-MYC in real blood samples. The sensing scheme relies on the use of specifically designed hybrid plasmonic materials and their bioderivatization with a selective peptidic receptor modified with a SERS transducer. Peptide/c-MYC recognition events translate into measurable alterations of the SERS spectra associated with a molecular reorientation of the transducer, in agreement with the surface selection rules. The efficiency of the sensor is demonstrated in cellular lines, healthy donors and a cancer patient This work was funded by Marie Curie Actions (FP7/2007-2013, TECNIOspring no. 600388 and PrioSERS FP72014-623527), the European Research Council (Advanced Grant No. 340055), the Spanish MINECO (CTQ2014-59808R, SAF2013-41943-R, CTQ2015-70698-R, CTQ2013-49317-EXP and the orfeo-cinqa network), the Generalitat of Catalonia (2014-SGR-480, AGAUR 2014 052 and AGAUR 2014 054), the Xunta de Galicia (GRC2013-041), and Medcom Advance S.A. SI
Published: 2016
Full Text: View/download PDF

31. Recomendaciones sobre el diagnóstico y tratamiento de la infección urinaria

Author: Juan Rico, Carlos Rodrigo Gonzalo de Liria, Cristina Calvo, Begoña Carazo Gallego, Alicia Berghezan Suárez, Josefa Ares Álvarez, María José Cilleruelo Ortega, Roberto Velasco Zúñiga, Juan José García García, Fernando Baquero-Artigao, César Joaquín García Vera, Marisa Herreros, Leticia Martínez Campos, Roi Piñeiro Pérez, Antonio José Conejo Fernández, Santiago Alfayate Miguélez, and Grupo Colaborador de Infección Urinaria en Pediatría
Subjects: 03 medical and health sciences, 0302 clinical medicine, Antibiotics, 030225 pediatrics, Diagnosis, Pediatrics, Perinatology and Child Health, Appropriateness, Consensus document, Urinary tract infections, Children, Pediatrics, RJ1-570
Abstract: Resumen: La infección del tracto urinario se define como el crecimiento de microorganismos en orina recogida de forma estéril, en un paciente con síntomas clínicos compatibles. En ausencia de sintomatología el aislamiento de bacterias en urocultivo se denomina bacteriuria asintomática y no precisa tratamiento. En neonatos y lactantes el signo guía para sospechar una infección del tracto urinario es la fiebre. En niños continentes los síntomas urinarios clásicos cobran mayor importancia. El diagnóstico requiere siempre la recogida de urocultivo previo al inicio de tratamiento antibiótico. En niños continentes la muestra de orina para urocultivo se debe recoger por micción espontánea. En niños no continentes mediante sondaje vesical, pudiendo optar por punción suprapúbica en neonatos y lactantes pequeños. No se debe enviar para urocultivo una muestra recogida mediante bolsa adhesiva. No se han demostrado diferencias significativas en la evolución clínica y desarrollo de secuelas entre la administración antibiótica oral exclusiva frente a la intravenosa de corta duración seguida de administración oral. La selección de la antibioterapia empírica inicial se basará en el patrón local de susceptibilidad. En la cistitis este consenso recomienda el uso empírico de cefalosporinas de segunda generación en menores de 6 años y fosfomicina trometamol en mayores. La antibioterapia empírica recomendada en pielonefritis que no precisan ingreso son las cefalosporinas de tercera generación. En caso de precisar ingreso se recomiendan los aminoglucósidos. En menores de 3 meses se debe añadir ampicilina. Una vez conocido el resultado del cultivo se debe dirigir el tratamiento de continuación, tanto intravenoso como oral. Abstract: Urinary tract infection (UTI) is defined as the growth of microorganisms in a sterile urine culture in a patient with compatible clinical symptoms. The presence of bacteria without any symptoms is known as asymptomatic bacteriuria, and does not require any treatment. In neonates and infants, fever is the guiding sign to suspecting a UTI. Classic urinary tract symptoms become more important in older children. Urine cultures collected before starting antibiotics is always required for diagnosis. Clean-catch (midstream) specimens should be collected for urine culture. In the case of non-toilet-trained children, specimens must be obtained by urinary catheterisation, or suprapubic puncture in neonates and infants. Specimens collected by urine bag should not be used for urine culture. There are no significant differences in the clinical evolution and prognosis between oral versus short intravenous followed by oral antibiotic. Empirical antibiotic therapy should be guided by local susceptibility patterns. Second-generation cephalosporin (children under 6 years) and fosfomycin trometamol (over 6 years), are the empiric therapy recommended in this consensus. In the case of pyelonephritis, recommended antibiotic treatment are third-generation cephalosporins (outpatient care) or, if admission is required, aminoglycosides. Ampicillin should be added in infants less than 3 months old. Antibiotic de-escalation should be always practiced once the result of the urine culture is known.
Published: 2019

32. Propuestas de mejora en el proceso de la solicitud comercial en Milestone para minimizar el tiempo de respuesta

Author: Salgado Beltrán, Astrid Johana, Jiménez Nieto, Yesid Ricardo, Pinzón Alfonso, Cristian Hernán, Gómez Rico, Carlos Eduardo, Ibañez Ovalle, Genny Liliana, Cárdenas Suárez, Diana Mercy, and Batiste, Sergi
Subjects: Rediseño cadena de valor, Value chain redesign, Diagnosis, Optimización de proceso, Diágnostico, Process optimization
Abstract: En la elaboración del artículo se logra identificar cuatro (4) soluciones óptimas, para rediseñar y mejorar el tiempo de respuesta; se realizó un diagnostico en Milestone donde se puede observar que la entrega de la cotización es máximo de 90 días calendario, esta problemática permitió hacer una investigación de las herramientas apropiadas para minimizar este tiempo, al realizar la investigación mediante un brainstorming teniendo como principal herramienta Lean Desing. El rediseño del proceso, formulario dinámico, tablero Kanban y capacitación como soluciones viables, con alcances definidos en cada una de estas estrategias dentro de la ejecución del proyecto. Las herramientas tecnológicas se muestran como una gestión potente y muy útil en la elaboración de tableros Kanban ya que nos muestran el desarrollo de nuestros proyectos y la implementación de las características de la teoría lean. Con estas herramientas se logra suplir las necesidades que tiene Milestone, y conseguirá aumentar la eficiencia en la ejecución en cada una los objetivos de la compañía. Pregrado Ingeniero en Industrial Ingeniería Industrial
Published: 2016

33. Electrocardiographic parameters in captive, clinically healthy, Amazona ochrocephala

Author: Guerrero S, Claudia, Bolivar B, Janeth, Vargas-Pinto, Piero, Vargas-Pinto, Pedro, and Brieva-Rico, Claudia
Subjects: diagnosis, electrocardiography, Amazona ochrocephala, electrocardiografía, diagnóstico
Abstract: Objective. To stablish the electrocardiographic parameters of individuals of the species Amazona ochrocephala, from the Unidad de Rescate y Rehabilitacion de Animales Silvestres at the Universidad Nacional de Colombia. Materials and methods. The electrocardiographic examination was performed under inhaled anesthesia with isoflurane. Leads I, II, III, aVL, aVR and aVF were measured. Results. Electrocardiographic parameters obtained in Lead II. P wave Duration: 0.015-0.044 s, P wave amplitude: 0.031 to 0.6 mv, R wave duration: 0.015-0.022 s, amplitude R: 0.034-0.038 mv, S wave Duration: 0.019- 0.042 s, amplitude S: 0.194-0.815 mv, T wave Duration: 0.025-0.064 s, T-wave amplitude: 0.010 to 0.5 mv, PQ Duration: 0.021-0.076 s, QRS Duration: 0.036-0.068 s, QT Duration: 0.070-0.015 s, RR Duration: 0.104-0.324 s, EEM: -111° to -80°, FC: 240-600 ppm. Conclusions. The results showed different values for amplitude and duration of the P, R and T waves in comparison to those obtained in other studies. However, they were similar for heart rate, MEA and duration of the PQ/R, QT and QRS segments. Objetivo. Establecer los parámetros electrocardiográficos en individuos de la especie Amazona ochrocephala, de la Unidad de Rescate y Rehabilitación de Animales Silvestres de la Universidad Nacional de Colombia sede Bogotá. Materiales y Métodos. El examen electrocardiográfico se realizó bajo anestesia inhalada con Isoflurano. Se tomaron derivadas I, II, III, aVL, aVR y aVF y posterior medición de ondas e intervalos usando magnificación con lupa. Resultados. Parámetros electrocardiográficos de la segunda derivada. Duración onda P: 0.015-0.044 s, amplitud onda P: 0.031-0.6 mv, duración onda R: 0.015-0.022 s, amplitud R: 0.034-0.038 mv, Duración onda S: 0.019- 0.042 s, Amplitud S: 0.194-0.815 mv, Duración onda T: 0.025-0.064 s, Amplitud onda T: 0.010-0.5 mv, Duración PQ: 0.021-0.076 s, Duración QRS: 0.036-0.068 s, Duración QT: 0.070-0.015 s, Duración R-R: 0.104-0.324 s, EEM: -111° a -80°, FC: 240-600 ppm. Conclusiones. Los resultados mostraron valores diferentes para los rangos de amplitud y duración de las deflexiones P, R y T en comparación a los obtenidos en otros estudios pero similares en cuanto al rango de frecuencia cardiaca, EEM y a la duración de los segmentos PQ/R, QT y QRS.
Published: 2015

34. Electrocardiographic parameters in captive, clinically healthy, Amazona ochrocephala

Author: Janeth Bolivar B, Claudia Brieva-Rico, Pedro Vargas-Pinto, Claudia Guerrero S, and Piero Vargas-Pinto
Subjects: Amazona ochrocephala, medicine.medical_specialty, diagnosis, electrocardiography, Aquatic Science, QRS complex, T wave, Internal medicine, Heart rate, medicine, T wave duration, lcsh:Veterinary medicine, General Veterinary, medicine.diagnostic_test, biology, business.industry, biology.organism_classification, Amplitude, Isoflurane, Anesthesia, Cardiology, lcsh:SF600-1100, Animal Science and Zoology, business, Electrocardiography, medicine.drug
Abstract: Objective. To stablish the electrocardiographic parameters of individuals of the species Amazona ochrocephala, from the Unidad de Rescate y Rehabilitacion de Animales Silvestres at the Universidad Nacional de Colombia. Materials and methods. The electrocardiographic examination was performed under inhaled anesthesia with isoflurane. Leads I, II, III, aVL, aVR and aVF were measured. Results. Electrocardiographic parameters obtained in Lead II. P wave Duration: 0.015-0.044 s, P wave amplitude: 0.031 to 0.6 mv, R wave duration: 0.015-0.022 s, amplitude R: 0.034-0.038 mv, S wave Duration: 0.019- 0.042 s, amplitude S: 0.194-0.815 mv, T wave Duration: 0.025-0.064 s, T-wave amplitude: 0.010 to 0.5 mv, PQ Duration: 0.021-0.076 s, QRS Duration: 0.036-0.068 s, QT Duration: 0.070-0.015 s, RR Duration: 0.104-0.324 s, EEM: -111° to -80°, FC: 240-600 ppm. Conclusions. The results showed different values for amplitude and duration of the P, R and T waves in comparison to those obtained in other studies. However, they were similar for heart rate, MEA and duration of the PQ/R, QT and QRS segments.
Published: 2015

35. Trichosporon spp como agente causal de onicomicosis

Author: Mendoza Mireya and Rico M Elena
Subjects: levaduras, lcsh:Arctic medicine. Tropical medicine, Trichosporon, diagnosis, lcsh:RC955-962, lcsh:Public aspects of medicine, onychomycosis, lcsh:RA1-1270, onicomicosis, diagnostico, yeast
Abstract: The incidence of Trichosporon spp. yeast isolates from clinical samples tested in the Mycology Laboratory at the Institute of Biomedicine over a period of 10 years (2000-2010) was evaluated. There was a total of 14 cases, representing an incidence of 0.13%; the cases showed 71% positivity on direct examination. 57% of the cases were in nails of the hand and foot. In contrast to cases reported for Candida, toenails were the most affected (50%) by Trichosporon spp. in this study. Resumen: Se evaluó la incidencia de aislados de la levadura de Trichosporon spp. a partir de las muestras clínicas procesadas en el Laboratorio de Micología del Instituto de Biomedicina en un lapso de 10 años (2000-2010). Encontrándose un total de 14 casos, lo que represento una incidencia del 0,13%, los casos mostraron 71% de positividad en el examen directo. El 57% de los casos fueron uñas de mano y pie, al contrario de lo reportado en Candida, las uñas de pie fueron las más afectadas (50%) por el Trichosporon spp. en este estudio.
Published: 2011

36. La gammagrafía con leucocitos marcados con 99mTc-HMPAO en el diagnóstico y seguimiento de la enfermedad inflamatoria intestinal

Author: A Antón Leal, Juan Ramírez Muñoz, A. Martínez Caballero, M Juste Ruiz, J. Verdú Rico, J.M. Muñoz Acosta, O Caballero Carpena, and R Jover
Subjects: Gynecology, Labeled leukocytes, medicine.medical_specialty, business.industry, medicine.disease, Inflammatory bowel disease, Pediatrics, RJ1-570, Crohn's disease, Ulcerative colitis, Pediatrics, Perinatology and Child Health, Diagnosis, medicine, HMPAO, business
Abstract: Para valorar si la gammagrafía con leucocitos marcados con 99mTc-HMPAO (GLM) es útil en el diagnóstico y seguimiento de la enfermedad inflamatoria intestinal (EII) en pediatría, se han estudiado retrospectivamente 33 pacientes, 15 varones, edad 10,7 ± 2,2 años, con sospecha de EII. El total de exploraciones ha sido 58, 29 con fines diagnósticos, 23 para el seguimiento de la enfermedad, y seis para la detección de recidiva. En el diagnóstico se comparó la GLM con la clínica (PCDAI), estudio analítico de sangre, radiología con contraste baritado (RCB; n = 22), ecografía (ECO; n = 22), colonoscopia (n = 16) y biopsia (n = 13). El diagnóstico final fue: enfermedad de Crohn (n = 12), colitis ulcerosa (n = 4), y no EII (n = 17). En los 17 pacientes sin EII la GLM fue siempre normal. Entre los 16 pacientes con EII la concordancia de resultados de la GLM con RCB fue 7/10, con ECO 6/11, con colonoscopia 9/12, y con biopsia 8/9. Conforme aumentó el grado de severidad en la GLM se incrementó el PCDAI (p
Published: 2006

37. Flow cytometry "Ogata score" for the diagnosis of myelodysplastic syndromes in a real‐life setting. A Latin American experience.

Author: Grille Montauban, Sofía, Hernandez‐Perez, Carlos R., Velloso, Elvira D. R. P., Novoa, Viviana, Lorand‐Metze, Irene, Gonzalez, Jaqueline, Solari, Liliana, Cismondi, Valeria, Serrano, Juan Carlos, Burgnini, Andreína, Rabelo‐Carrasco, Laura J., Bacal, Nydia, Trias, Natalia, Guevara, Romina, Rico Vido, Joyce, Crisp, Renee, Enrico, Alicia, Boada, Matilde, Pereira Cunha, Fernanda G., and Fanessi, Viviana
Subjects: CONFIDENCE intervals, FLOW cytometry, RESEARCH methodology, MYELODYSPLASTIC syndromes, RESEARCH evaluation, PREDICTIVE tests, CASE-control method, RESEARCH methodology evaluation
Abstract: Introduction: Flow cytometry (FC) is a helpful tool for the diagnosis of myelodysplastic syndrome (MDS). Different FC score systems have been developed. The "Ogata score" is a simple diagnostic score that has been validated having a sensitivity of 69% and a specificity of 92% in low‐risk MDS. We aimed to study the feasibility and the utility of the "Ogata score" for the diagnosis of MDS among Latin America (LA) Laboratories. Methods: This is a case and control study conducted in LA institutions members of Grupo Latinoamericano de Mielodisplasia (GLAM). A total of 146 MDS patients and 57 control patients were included. "Ogata score" was calculated. Results: The sensitivity of "Ogata score" was 75.6% (95% CI, 66.8‐81.3), specificity was 91.2% (95% CI, 79.7‐96.7), PPV was 95.6% (95% CI, 88.5‐98.3), and NPV was 65.4% (95% CI, 49.1‐71.9). In low/intermediate‐1 IPSS patients group, the sensitivity was 70.1% (95% CI, 60.2‐78.2), specificity was 91.2% (CI‐95%, 79.7‐96.7), PPV was 94.2% (95% CI, 86.4‐97.8), and NPV was 62.1% (95% CI, 53.0‐78.7). In the group of patients "without MDS specific markers" (patients without ring sideroblasts, blast excess, or chromosomal abnormalities), the sensitivity was 66.7% (CI‐95%, 55.8‐76.0), specificity was 91.2% (95% CI, 79.7‐96.7), PPV was 92.3% (95% CI, 82.2‐97.1), and NPV was 63.5% (95% CI, 51.9‐73.5). Conclusions: The diagnostic power found in this study was similar to the reported by Della‐Porta et al. Also in LA, the analysis was made in modern equipment with acquisition of at least 100 000 events which permits a good reproducibility of the results. [ABSTRACT FROM AUTHOR]
Published: 2019
Full Text: View/download PDF

38. Feasibility of a dance and exercise with music programme on adults with intellectual disability.

Author: Martínez‐Aldao, D., Martínez‐Lemos, I., Bouzas‐Rico, S., and Ayán‐Pérez, C.
Subjects: SKELETAL muscle physiology, BODY composition, CARDIOVASCULAR system physiology, DANCE, DIAGNOSIS, EXERCISE physiology, EXERCISE tests, GAIT in humans, HEALTH promotion, JUMPING, PEOPLE with intellectual disabilities, MUSCLE strength, MUSIC, PATIENT compliance, PHYSICAL fitness, PSYCHOLOGY of People with disabilities, STANDING position, DISABILITIES, BODY mass index, EVALUATION of human services programs, CARDIOPULMONARY fitness
Abstract: Background: Research regarding the feasibility and effects of dancing and exercise with musical support programmes on the physical fitness of adults with intellectual disability (ID) is scarce. The purpose of this study was to provide scientific evidence regarding the feasibility of a training programme consisting of dancing and exercise with music designed for adults with ID, as well as to assess its impact on their body composition and cardiovascular and muscular fitness. Methods: A total of 30 adults (mean age 36.37 ± 11.24 years) with mild (n = 13), moderate (n = 16) or severe (n = 1) ID took part in a 10‐week dancing and exercise with music programme. Recruitment and completion rate, adherence to the programme, participation and adverse effects were registered as measures of feasibility. The body mass index, cardiovascular endurance (6‐min walk test) and muscular strength (standing long jump test) of the participants were assessed in order to determine the effects of the programme on their fitness level. Results: A 92.5% recruitment rate and a 90% completion rate were achieved. Adherence to the programme stood at 76.6%, and no adverse effects were registered. The comparison between the values obtained in the initial and final evaluations indicated the existence of positive changes in all the fitness dimensions measured. Conclusion: A training programme combining dancing and exercise with music proved to be feasible when performed by adults with ID. These kind of programmes can have a positive effect on the fitness level of this specific group. [ABSTRACT FROM AUTHOR]
Published: 2019
Full Text: View/download PDF

39. Characterization and Etiopathogenic Approach of Pediatric Renal Biopsy Patients in a Colombian Medical Center from 2007-2017.

Author: Prada Rico, Mayerly, Rodríguez Cuellar, Carmen Inés, Fernandez Hernandez, Monica, González Chaparro, Luz Stella, Prado Agredo, Olga Lucía, and Gastelbondo Amaya, Ricardo
Subjects: *GENETIC disorder diagnosis, *KIDNEY disease diagnosis, *KIDNEY surgery, *BIOPSY, *GLOMERULONEPHRITIS, *HEMATURIA, *KIDNEY diseases, *RESEARCH methodology, *NEPHROTIC syndrome, *PEDIATRICS, *PROTEINURIA, *DESCRIPTIVE statistics, *DIAGNOSIS, *PROGNOSIS
Abstract: Introduction. Renal biopsy is the principal instrument to evaluate the diagnosis and prognosis of children with kidney disease. There are relatively few studies establishing epidemiology of its findings in the pediatric population. Methods. A descriptive study was conducted to describe characteristics of pediatric patients who had undergone a renal biopsy over the last 10 years in a national reference center, trying to accomplish an etiopathogenic approach of biopsy findings. Results. 241 patients were included. Most frequent indications were nephrotic syndrome (34.1%) and systemic disease with renal involvement (30.2%). The most prevalent biopsy diagnosis was glomerulonephritis (44%) and among these patients, glomerulonephritis mediated by immune complexes was the most frequent pathogenic type (90.5%). When the biopsy was indicated for proteinuria plus hematuria and systemic disease with renal involvement, the most frequent biopsy diagnosis was glomerulonephritis (60 and 85%, respectively). For isolated hematuria, the predominant biopsy diagnosis was inherited diseases of the glomerular basement membrane (70%) and for nephrotic syndrome, podocytopathy (82%). Glomerulonephritis was more frequent in patients older than 10 yrs (65%) and the rate of postbiopsy major complications was low (1.2%). Conclusion. Immune complex glomerulonephritis was the most frequent histological finding, differing from previous reports. To our knowledge this is the first description that classifies biopsy findings according to the probable pathogenic mechanism. [ABSTRACT FROM AUTHOR]
Published: 2018
Full Text: View/download PDF

40. Minimal hepatic encephalopathy identifies patients at risk of faster cirrhosis progression.

Author: Ampuero, Javier, Montoliú, Carmina, Simón‐talero, Macarena, Aguilera, Virginia, Millán, Raquel, Márquez, Celina, Jover, Rodrigo, Rico, María Carmen, Sendra, Carmen, Serra, Miguel Ángel, and Romero‐gómez, Manuel
Subjects: HEPATIC encephalopathy, CIRRHOSIS of the liver, DISEASE progression, LIVER transplantation, DIAGNOSIS, DISEASE risk factors
Abstract: Abstract: Background and Aim: Minimal hepatic encephalopathy (MHE) predicts poor prognosis and could reflect an advanced liver disease. We aimed to assess whether MHE could be a surrogate marker of a further liver disease. Methods: Prospective multicenter study including 320 cirrhotic patients, followed for up to 5 years, which were classified at baseline in compensated cirrhosis without (stage 1) and with varices (stage 2), one decompensating event (stage 3), and any second decompensating event (stage 4). Cirrhosis progression was defined by a transition towards a different stage (competing events: liver transplant due to hepatocellular carcinoma and non‐liver‐related death). MHE was detected by critical flicker frequency and psychometric tests. Results: Minimal hepatic encephalopathy was diagnosed in 18.2% (57/314) of patients. Cirrhosis progression occurred in 38.1% (122/320) of patients, while liver transplant was required in 10.9% (35/320), and 19.1% (61/320) died. In competing risk regression, MHE was associated with disease progression: model 1 {subhazard ratio [sHR] 2.34 [95%confidence interval (CI) 1.58–3.46]; P = 0.0001}; model 2 [sHR 2.18 (95%CI 1.43–3.33); P = 0.0001]; model 3 [sHR 2.48 (95%CI 1.63–3.76); P = 0.0001]. The annual incidence rate of progression was higher in MHE patients: stage 1 (19.4 vs 5.6 cases per 100 person‐years); stage 2 (26.8 vs 15.6); stage 3 (45.7 vs 16.5); and stage 4 (40.7 vs 12.8). MHE showed a higher cumulative incidence of disease progression from the first year in decompensated and the third year in compensated cirrhosis. Conclusion: Minimal hepatic encephalopathy was associated with cirrhosis progression and showed a higher cumulative and annual incidence rate of disease progression. MHE could be a surrogate marker of disease progression, irrespective of cirrhosis status, identifying patients at risk of suffering a more aggressive cirrhosis form. [ABSTRACT FROM AUTHOR]
Published: 2018
Full Text: View/download PDF

41. Evaluation of vascular features of vocal cords proposed by the European Laryngological Society.

Author: Šifrer, Robert, Rijken, Johannes A., Leemans, C. René, Eerenstein, Simone E. J., van Weert, Stijn, Hendrickx, Jan-Jaap, Bloemena, Elisabeth, Heuveling, Derrek A., and Rinkel, Rico N. P. M.
Subjects: VOCAL cord cancer, BENIGN tumors, BLOOD vessels, LARYNGOSCOPY, PAPILLOMA, GLOTTIS, FOLLOW-up studies (Medicine), DIAGNOSIS, PHYSIOLOGY
Abstract: A newly proposed classification by the European Laryngological Society (ELS) of glottic lesions by narrow-band imaging (NBI) divides their vascular patterns into longitudinal and perpendicular ones. The latter are further subdivided into the wide and narrow patterns. The longitudinal, wide, and narrow patterns are characteristic of benign disease, papilloma, and malignancy, respectively. The aim of the study was to investigate the diagnostic effectiveness of the classification. Forty patients with glottic lesions underwent microlaryngoscopy. The vascular patterns of all vocal cords were defined with NBI. The affected vocal cords were histologically analysed and comprised the arm (A). Unaffected vocal cords were not histologically analysed but followed-up and comprised the arm (B) and were regarded as true negatives if no suspicious changes appeared during the follow-up. The vocal cords from the arm A were categorised into the benign and malignant group according to the histologic result. The ratio of vascular patterns was determined and the groups were statistically compared using the Chi-square test and Fisher's exact test. Perpendicular changes were observed in 36.6% (9/26) of benign diseases and in 100% (23/23) of cancer conditions ( p < 0.001). Wide perpendicular changes appeared only in papillomas (6/6) while narrow ones mostly in malignancies (23/26) and also in benign conditions (3/26) ( p < 0.001). The sensitivity, specificity, positive and negative predictive values, and accuracy were 100, 95, 88, 100 and 96%, respectively. The new ELS classification can be used effectively and safely to differentiate malignant from benign disease. [ABSTRACT FROM AUTHOR]
Published: 2018
Full Text: View/download PDF

42. Cancer characterization and diagnosis with SERS-encoded particles.

Author: Guerrini, Luca, Pazos-Perez, Nicolas, Alvarez-Puebla, Ramon, and Garcia-Rico, Eduardo
Subjects: CANCER treatment, BIOSENSORS, NANOMEDICINE, PLASMONICS, TUMORS
Abstract: Early diagnosis, monitoring and treatment selection of cancer represent major challenges in medicine. The definition of the complex clinical and molecular landscape of cancer requires the combination of multiple techniques and the investigation of multiple targets. As a result, diagnosis is normally lengthy, expensive and, in many cases, cannot be performed recursively. In recent years, optical biosensors, especially those based on the unique properties of plasmonic nanostructures, have emerged as one of the most exciting tools in nanomedicine, capable of overcoming key limitations of classical techniques. In this review, we specifically focus our attention on the latest advances in optical biosensors exploiting surface-enhanced Raman scattering encoded particles for the characterization of tumor single cells (molecular biology) and tissues (immunohistochemistry and guided surgery), as well as their application in guided surgery or even in bioimaging of living organisms. [ABSTRACT FROM AUTHOR]
Published: 2017
Full Text: View/download PDF

43. Trichosporon spp as a Causative Agent of Onychomycosis

Author: Mendoza, Mireya and Rico, M. Elena
Subjects: Trichosporon, diagnosis, onychomycosis, yeast
Abstract: The incidence of Trichosporon spp. yeast isolates from clinical samples tested in the Mycology Laboratory at the Institute of Biomedicine over a period of 10 years (2000-2010) was evaluated. There were a total of 14 cases, representing an incidence of 0.13%; the cases showed 71% positivity on direct examination. 57% of the cases were in nails of the hand and foot. In contrast to cases reported for Candida, toenails were the most affected (50%) by Trichosporon spp. in this study.
Published: 2011

44. Abordaje de la infección aguda del parénquima renal: estudio retrospectivo de los años 2005-2007

Author: Pérez Arbej, José Antonio and Cameo Rico, María Isabel
Subjects: Acute pyelonephritis, Pielonefritis aguda, Diagnóstico, Diagnosis, Estudio microbiológico, Microbiological study
Abstract: Objetivo: La infección aguda del parénquima renal, conocida como pielonefritis aguda (PNA), es diagnosticada y tratada en diversos Servicios del H.C.U. Lozano Blesa. Deseábamos averiguar si el proceso se realizaba de forma homogénea, ajustándose a los estándares de calidad descritos y si podíamos detectar áreas de mejora. Métodos: Estudio retrospectivo de pacientes ingresados con el diagnóstico de PNA, durante 2 años (1105/10-07), valorándose diversas variables, referidas a datos epidemiológicos, diagnóstico, tratamiento y evolución. Resultados: Se analizaron 118 pacientes (80,5% mujeres, edad media 34 años), que suponían el 0,39% de ingresos procedentes del S. Urgencias (el 36% en Urología y el resto en Pediatría, Obstetricia, Medicina Interna y otros Servicios). El 45% presentaba factores de riesgo (anomalías urinarias, diabetes, embarazo, inmunosupresión, etc.), considerándose como PNA complicadas (PNAC). Entre los niños hubo una elevada tasa de malformaciones del tracto urinario. El diagnóstico fue clínico en el 82,2%. El resto precisó técnicas de imagen, sobre todo los niños, en los que se utilizó gammagrafía. El 87,2% presentaban leucocituria y el 79,9% leucocitosis. Se realizó urocultivo pre-tratamiento en el 76,3%, con una tasa de positividad del 55,5%, detectándose gérmenes Gram negativos en el 94% (E. coli en el 82%). El tratamiento fue empírico en todos los casos, a base de cefalosporinas, amoxicilina/clavulánico y fluorquinolonas. La evolución fue favorable en el 93,2% de pacientes (95,1% de las PNANC y 85,7% de las PNAC). La estancia media global fue de 6,4 días (5,6 en PNANC y 7,5 en PNAC). Conclusiones: A la luz de la literatura revisada hemos comprobado que el manejo de esta patología, tal y como se lleva a cabo en el H.C.U. Lozano Blesa es altamente satisfactorio y se aproxima mucho a lo publicado por otros autores. Cabría destacar que se ha detectado una baja tasa de urocultivos pre-tratamiento, que los resultados de éstos son negativos en demasiados casos (por inicio precoz del tratamiento antibiótico) y que la estancia media, en la no complicada, debería reducirse. Queremos felicitar a todos los profesionales del Centro, implicados en el proceso analizado, por la "buena praxis" demostrada. Objectives: The renal parenchyma acute infection, known as acute pyelonephritis (APN), is diagnosed and treated in some Hospital Departments of the H.C.U. Lozano Blesa. We want to know if the process was made in a homogeneous way, fixed to the described quality standards and if we could detect improvement areas. Methods: Retrospective study in admitted patients with the diagnosis of APN over and 2 year period (1105/10-07), evaluating some variables referred to epidemiological data, diagnosis, treatment and evolution. Results: We studied 118 patients (80.5% women, mean age 34 years), that supposed 0.39% of patients admitted from the Emergency Department (36% in Urology and the rest in Paediatric, Obstetric, Internal Medicine and others). 45% showed risk factors (urinary anomalies, diabetes, pregnancy, immunosuppressant, ...), and it is considered complicated APN (CAPN). In children there was a high rate of urinary tract malformations. Diagnosis was clinical in 82.2%. The rest required imaging techniques, specially children, using gamma scan. In 82.7 % there was leukocyturia and in 79.9% leukocytosis. A urine culture pre-treatment was made in 76.3%, with a positive rate of 55.5%, detecting negative Gram germs in 94% (E. coli in 82%). Treatment was empiric in all cases, based on cephalosporin, amoxicillin/clavulanic acid and fluoroquinilones. Evolution was favorable in 93.1% (95.1% of NCAPN and 85.7% of CAPN). The mean hospital stay was 6.4 days (5.6 in NCAPN and 7.5 in CAPN). Conclusions: Acute pyelonephritis management in our hospital is highly satisfactory and similar to the revised medical literature. We could emphasize the low rate of urinary cultures pre-treatment (negative in quite a lot of the cases, due to early beginning of antibiotic treatment) and that mean hospital stay could be reduced in CAPN. We want to congratulate all involved professionals at the hospital for the good practice demonstrated.
Published: 2009

45. High concordance of findings obtained from transgluteal magnetic resonance imaging - and transrectal ultrasonography-guided biopsy as compared with prostatectomy specimens.

Author: Steurer, Stefan, Rico, Sebastian Dwertmann, Simon, Ronald, Minner, Sarah, Tsourlakis, Maria Christina, Krech, Till, Koop, Christina, Graefen, Markus, Heinzer, Hans, Adam, Meike, Huland, Hartwig, Schlomm, Thorsten, Sauter, Guido, and Lumiani, Agron
Subjects: *DIAGNOSIS, *PROSTATE cancer, *PROSTATE biopsy, *DIAGNOSTIC ultrasonic imaging, *PROSTATECTOMY, *MAGNETIC resonance imaging
Abstract: Objectives To determine the utility of our transgluteal magnetic resonance imaging ( MRI)-guided prostate biopsy approach. Patients and Methods A total of 960 biopsy series, taken within the period of 1 year, were evaluated, including 301 MRI-guided and 659 transrectal ultrasonography ( TRUS)-guided biopsies. Results The positivity rate and proportion of high grade cancers were significantly higher in MRI-guided than in TRUS-guided biopsies. Of 301 MRI-guided biopsies, 65.4% contained cancer while 57.2% of 659 TRUS biopsies contained cancer ( P = 0.016). Gleason grade 3 + 3 = 6 disease was observed in 16.8% of 197 MRI-guided and in 36.1% of 377 TRUS-guided biopsies ( P < 0.001). There was also a markedly higher quantity of cancer tissue in MRI-guided biopsies. In all cancers, the mean cancer surface area was 64.8 ± 51.6 mm2 in MRI-guided biopsies as compared with 23.0 ± 31.4 mm2 in non- MRI-guided biopsies ( P < 0.001). With respect to the tissue quantity, superiority of MRI-guided biopsy was highest in Gleason grade 3 + 3 = 6 cancers (20.9 ± 27.9 vs 5.1 ± 10.2 mm2; P < 0.001) and in Gleason grade 3 + 4 = 7 cancers (59.7 ± 38.0 vs 17.7 ± 18.4 mm2; P < 0.001). Comparison of biopsy Gleason grades with findings in prostatectomy specimens was possible in 80 patients with MRI-guided and in 170 patients with non- MRI-guided biopsies. This comparison showed a very high but almost identical concordance of TRUS- and MRI-guided biopsies with the prostatectomy specimen findings. With both approaches, undetected high-risk cancers were present in ~10% of patients with low-risk biopsy results. A significant difference was observed, however, in the proportion of patients who had clinically insignificant cancers and who underwent surgery. The proportion of patients with Gleason grade 3 + 3 = 6 carcinoma in their prostatectomy specimen was 11.2% in the post- TRUS biopsy cohort, but only 2.5% in the post- MRI biopsy cohort ( P = 0.021). Conclusion MRI-guided transgluteal prostate biopsy has a high detection rate for high-risk carcinomas, while the risk of detecting clinically insignificant carcinomas appears to be reduced. This may by itself lead to a reduction of unnecessary prostatectomies. Overtreatment may be further avoided by better applicability of molecular testing to MRI-guided biopsies because of the excessive amount of tissue available for analysis, especially in patients with potential low-risk carcinomas. [ABSTRACT FROM AUTHOR]
Published: 2017
Full Text: View/download PDF

46. Lipoma gigante de muslo. Reporte de un caso.

Author: Carriedo-Rico, E. G. and García-Morato-Jorreto, P.
Abstract: Lipoma is a tumor of adipose tissue cells that can develop in any part of the body; We present the case of an 86-year-old woman with a lesion of the left thigh as well as her diagnostic approach, specific surgical treatment and histopathological analysis. Three years after its resection, the function of the lower extremity was preserved. [ABSTRACT FROM AUTHOR]
Published: 2017

47. Estimation of renal function by CKD-EPI versus MDRD in a cohort of HIV-infected patients: a cross-sectional analysis.

Author: Cristelli, M. P., Cofán, F., Rico, N., Trullàs, J. C., Manzardo, C., Agüero, F., Bedini, J. L., Moreno, A., Oppenheimer, F., Miro, J. M., and CKD-H. Clinic Investigators
Subjects: MEDICAL care of HIV-positive persons, KIDNEY function tests, GLOMERULAR filtration rate, KIDNEY diseases, HIV infections, HIV infection complications, BIOLOGICAL models, CHRONIC kidney failure, COMPARATIVE studies, COMPUTER simulation, RESEARCH methodology, MEDICAL cooperation, RESEARCH, RESEARCH evaluation, EVALUATION research, CROSS-sectional method, COMPUTER-aided diagnosis, DIAGNOSIS
Abstract: Background: Accurately determining renal function is essential for clinical management of HIV patients. Classically, it has been evaluated by estimating glomerular filtration rate (eGFR) with the MDRD-equation, but today there is evidence that the new Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation has greater diagnostic accuracy. To date, however, little information exists on patients with HIV-infection. This study aimed to evaluate eGFR by CKD-EPI vs. MDRD equations and to stratify renal function according to KDIGO guidelines.Methods: Cross-sectional, single center study including adult patients with HIV-infection.Results: Four thousand five hundred three patients with HIV-infection (864 women; 19%) were examined. Median age was 45 years (IQR 37-52), and median baseline creatinine was 0.93 mg/dL (IQR 0.82-1.05). A similar distribution of absolute measures of eGFR was found using both formulas (p = 0.548). Baseline median eGFR was 95.2 and 90.4 mL/min/1.73 m2 for CKD-EPI and MDRD equations (p < 0.001), respectively. Of the 4503 measurements, 4109 (91.2%) agreed, with a kappa index of 0.803. MDRD classified 7.3% of patients as "mild reduced GFR" who were classified as "normal function" with CKD-EPI. Using CKD-EPI, it was possible to identify "normal function" (>90 mL/min/1.73 m2) in 73% patients and "mild reduced GFR" (60-89 mL/min/1.73 m2) in 24.3% of the patients, formerly classified as >60 mL/min/1.73 m2 with MDRD.Conclusions: There was good correlation between CKD-EPI and MDRD. Estimating renal function using CKD-EPI equation allowed better staging of renal function and should be considered the method of choice. CKD-EPI identified a significant proportion of patients (24%) with mild reduced GFR (60-89 mL/min/1.73 m2). [ABSTRACT FROM AUTHOR]
Published: 2017
Full Text: View/download PDF

48. Effects of combined rAAV-mediated TGF-β and sox9 gene transfer and overexpression on the metabolic and chondrogenic activities in human bone marrow aspirates.

Author: Tao, Ke, Rey-Rico, Ana, Frisch, Janina, Venkatesan, Jagadeesh, Schmitt, Gertrud, Madry, Henning, Lin, Jianhao, and Cucchiarini, Magali
Subjects: BONE marrow diseases, TRANSFORMING growth factors-beta, CHONDROGENESIS, ARTICULAR cartilage diseases, GENETIC transformation, TRANSCRIPTION factors, DIAGNOSIS, THERAPEUTICS
Abstract: Background: Transplantation of genetically modified bone marrow concentrates is an attractive approach to conveniently activate the chondrogenic differentiation processes as a means to improve the intrinsic repair capacities of damaged articular cartilage. Methods: Human bone marrow aspirates were co-transduced with recombinant adeno-associated virus (rAAV) vectors to overexpress the pleiotropic transformation growth factor beta (TGF-β) and the cartilage-specific transcription factor sox9 as a means to enhance the chondroreparative processes in conditions of specific lineage differentiation. Results: Successful TGF-β/ sox9 combined gene transfer and overexpression via rAAV was achieved in chondrogenically induced human bone marrow aspirates for up to 21 days, the longest time point evaluated, leading to increased proliferation, matrix synthesis, and chondrogenic differentiation relative to control treatments (reporter lacZ treatment, absence of vector application) especially when co-applying the candidate vectors at the highest vector doses tested. Optimal co-administration of TGF-β with sox9 also advantageously reduced hypertrophic differentiation in the aspirates. Conclusions: These findings report the possibility of directly modifying bone marrow aspirates by combined therapeutic gene transfer as a potent and convenient future approach to improve the repair of articular cartilage lesions. [ABSTRACT FROM AUTHOR]
Published: 2017
Full Text: View/download PDF

49. Central Body Fat Mass Measured by Bioelectrical Impedanciometry But Not Body Mass Index Is a High-Grade Prostate Cancer Risk Factor.

Author: Morán Pascual, Eduardo, Martínez Sarmiento, Manuel, Budía alba, alberto, Broseta Rico, Enrique, Cámara Gómez, Rosa, and Boronat Tormo, Francisco
Subjects: DIAGNOSIS, PROSTATE cancer, PROSTATE cancer risk factors, FAT measurement, BODY mass index, PROSTATE biopsy
Abstract: Objective: To evaluate the association between body fat mass distribution measured by bioelectrical impedanciometry (BEI) and high-grade prostate cancer (HGPC). Methods: We prospectively analyze 323 patients who underwent prostate biopsy. BEI was performed prior to biopsy. Prostate cancer (PC) was stratified according to D'Amico classification. For univariate analysis, Student t test was done. For multivariate analysis, bivariate logistic regression was performed using PSA, body mass index (BMI), percentage central body fat, percentage total body fat, and visceral fat as explicative variables for the diagnosis of HGPC. Results: PC was found in 134 patients. Thirty seven (27.2%) were HGPC. This group had higher age, PSA, and percentage central body fat (p = 0.001, p = 0.001, p = 0.04). BMI showed no association with HRPC. Age, PSA, and percentage central body fat (OR 1,123, 95% CI 1,022-1,233, p = 0.001) were independent risk factors. Conclusions: Central body fat measured by BEI could explain the association between obesity and HGPC better than BMI suggesting the use of this technique to study body fat distribution. [ABSTRACT FROM AUTHOR]
Published: 2017
Full Text: View/download PDF

50. Biomarker tools to Design Clinical Vaccines Determined from a study of annual Listeriosis Incidence in Northern spain.

Author: Calderon-Gonzalez, Ricardo, Teran-Navarro, Hector, Marimon, José María, González-Rico, Claudia, Calvo-Montes, Jorge, Frande-Cabanes, Elisabet, Alkorta-Gurrutxaga, Miriam, Fariñas, M. C., Martínez-Martínez, Luis, Perez-Trallero, Emilio, Alvarez-Dominguez, Carmen, Dussurget, Olivier, and Schmidt, Rebecca Leigh
Subjects: LISTERIOSIS, BIOMARKERS, PUBLIC health, DIAGNOSIS
Abstract: Two regions of northern Spain, Gipuzkoa, and Cantabria present high annual incidence of listeriosis (1.86 and 1.71 cases per 100,000 inhabitants, respectively). We report that the high annual incidences are a consequence of infection with highly virulent Listeria monocytogenes isolates linked to fatal outcomes in elderly patients with cancer. In addition, listeriosis patients with cancer present low IL-17A/IL-6 ratios and significantly reduced levels of anti-GAPDH1-22 antibodies, identified as two novel biomarkers of poor prognosis. Analysis of these biomarkers may aid in reducing the incidence of listeriosis. Moreover, GAPDH1-22-activated monocyte-derived dendritic cells of listeriosis patients with cancer seem useful tools to prepare clinical vaccines as they produce mainly Th1 cytokines. [ABSTRACT FROM AUTHOR]
Published: 2016
Full Text: View/download PDF

Catalog

Books, media, physical & digital resources

See catalog results

Searchworks

Select search scope, currently: Articles Catalog books, media & more in Jio Institute collections Articles journal articles & other e-resources

Search

Search Constraints

Refine your results

Search Limiters

Topic

Publication Year Range

Language

Publication Type

Journal

Region

Database

Publisher

164 results on '"Rico A"'

Search Results

Catalog

Select search scope, currently: Articles

Catalog

books, media & more in Jio Institute collections

Articles

journal articles & other e-resources